MCID: IRR003
MIFTS: 53

Irritant Dermatitis

Categories: Immune diseases, Skin diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Irritant Dermatitis

MalaCards integrated aliases for Irritant Dermatitis:

Name: Irritant Dermatitis 11 14 16 33
Irritant Contact Dermatitis 11 75 31 33
Primary Irritant Dermatitis 11 33
Dermatitis, Irritant 43 71
Irritant Contact Eczema Due to Exposure to Acids, Alkalis or Other Chemical Irritants 33
Irritant Contact Eczema Due to Friction, Sweating or Contact with Body Fluids 33
Irritant Contact Eczema Due to Topical Medicaments or Antimicrobials 33
Irritant Contact Eczema Due to Plants or Other Vegetable Matter 33
Irritant Contact Eczema Due to Cosmetics or Emollients 33
Irritant Contact Dermatitis, Unspecified Cause 33
Irritant Contact Dermatitis Due to Detergents 33
Irritant Contact Eczema Due to Incontinence 33
Irritant Contact Eczema Due to Wet Work 33
Irritant Contact Eczema Due to Solvents 33
Irritant Contact Eczema Due to Saliva 33
Irritant Contact Eczema Due to Foods 33
Icd - [irritant Contact Dermatitis] 33
Incontinence-Associated Dermatitis 33
Non-Allergic Contact Dermatitis 33
Contact Dermatitis, Irritant 75
Irritant Contact Eczema 33

Classifications:



Summaries for Irritant Dermatitis

Disease Ontology: 11 A contact dermatitis that is characterized by a cutaneous inflammatory reaction to repeated contact with an irritant substance, friction, liquid, or adverse temperature that interacts with the skin and often has symptom erythema, edema, scaling, pain, pruritis, or burning sensation.

MalaCards based summary: Irritant Dermatitis, also known as irritant contact dermatitis, is related to decubitus ulcer and occupational dermatitis, and has symptoms including erythema An important gene associated with Irritant Dermatitis is FLG (Filaggrin), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Sage and Mineral oil have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and neutrophil, and related phenotypes are immune system and digestive/alimentary

Wikipedia: 75 Irritant contact dermatitis is a form of contact dermatitis that can be divided into forms caused by... more...

Related Diseases for Irritant Dermatitis

Diseases related to Irritant Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 748, show less)
# Related Disease Score Top Affiliating Genes
1 decubitus ulcer 31.3 TNF IL6 IL1B CXCL8
2 occupational dermatitis 31.2 IL31 FLG
3 erysipelas 30.7 TNF IL6 IL1B
4 hemorrhoid 30.5 TNF IL6 IL1B
5 ichthyosis vulgaris 30.3 TSLP LORICRIN IVL FLG
6 chronic ulcer of skin 30.3 TNF IL6 IL1B CXCL8
7 apnea, obstructive sleep 30.3 TNF IL6 IL1B CXCL8
8 skin atrophy 30.2 TNF LORICRIN IL4 IL31 FLG
9 conjunctivitis 30.0 TNF IL6 IL4 IL13 CXCL8
10 hypersensitivity vasculitis 30.0 TNF IL6 CD4
11 dermatophytosis 29.9 TNF IL1B IL17A CD4
12 severe cutaneous adverse reaction 29.9 TNF IL6 CD4
13 alopecia 29.7 TNF IL6 IL4 IL1B IL17A FLG
14 vitiligo-associated multiple autoimmune disease susceptibility 1 29.7 TNF IL17A CD4
15 diarrhea 29.7 TNF TAC1 IL6 IL1B IL13 CXCL8
16 bullous pemphigoid 29.7 TNF IVL IL6 IL4 CXCL8 CCL17
17 erythema multiforme 29.6 TNF IL6 IL4 IL1B IL13 CXCL8
18 covid-19 29.6 TNF IL6 IL4 IL1B CXCL8 CXCL10
19 candidiasis 29.5 TNF IL6 IL4 IL1B IL1A IL17A
20 urinary tract infection 29.5 TNF IL6 IL1B CXCL8 CD4
21 scabies 29.4 IL4 IL31 IL13 FLG CD4
22 lymphangioma 29.3 TNF IL6 IL1B IL17A CXCL8 CD4
23 primary cutaneous t-cell non-hodgkin lymphoma 29.3 IL4 CXCL10 CD4 CCL17
24 pemphigoid 29.2 TNF IL6 IL4 IL31 IL1B IL17A
25 exanthem 29.1 TNF IL6 IL4 IL1B IL17A CXCL8
26 gingival disease 28.9 TNF IL6 IL4 IL1B IL1A IL17A
27 proteasome-associated autoinflammatory syndrome 1 28.8 TNF IL6 IL4 IL1B IL1A IL17A
28 dermatitis 28.6 TSLP TNF LORICRIN KRT16 IVL IL6
29 crohn's disease 28.6 TNF IL6 IL4 IL1B IL17A IL13
30 fungal infectious disease 28.4 TNF IL6 IL4 IL1B IL1A IL17A
31 urticaria 27.9 TSLP TNF TAC1 IL6 IL4 IL31
32 allergic disease 27.4 TSLP TNF TAC1 IL6 IL4 IL1B
33 contact dermatitis 27.0 TSLP TNF TAC1 LORICRIN KRT16 IVL
34 allergic contact dermatitis 26.8 TSLP TNF LORICRIN IVL IL6 IL4
35 psoriasis 26.8 TNF LORICRIN KRT16 IVL IL6 IL4
36 dermatitis, atopic 26.3 TSLP TNF TAC1 LORICRIN IVL IL6
37 skin disease 26.3 TSLP TNF TAC1 LORICRIN KRT16 IVL
38 phototoxic dermatitis 11.2
39 cholesteatoma of external ear 10.4 IL1A CXCL8
40 senile entropion 10.3 TNF CXCL8
41 clear cell acanthoma 10.3 IVL FLG
42 external pathological resorption 10.3 TNF IL6
43 cicatricial lagophthalmos 10.3 LORICRIN IVL FLG
44 kashin-beck disease 10.3 TNF IL1B
45 periostitis 10.3 TNF IL1B IL1A
46 periodontitis, chronic 10.3 IL6 IL1B
47 paratyphoid fever 10.3 TNF IL1B IL1A
48 ichthyosis, congenital, autosomal recessive 4b 10.3 LORICRIN IVL FLG
49 haemophilus influenzae 10.3 TNF IL1B CXCL8
50 indolent plasma cell myeloma 10.3 IL6 IL1B IL1A
51 enterocolitis 10.3 TNF IL6 CXCL8
52 physiological polycythemia 10.2 TNF IL6 IL1B
53 osteosclerotic myeloma 10.2 IL6 IL1B
54 pericoronitis 10.2 TNF IL6 IL1B
55 chronic apical periodontitis 10.2 TNF IL6 IL1B
56 mesenteric lymphadenitis 10.2 TNF IL6 IL1B
57 fasciitis 10.2 TNF IL6 CXCL8
58 inflammatory and toxic neuropathy 10.2 TNF IL6 IL1B
59 graves ophthalmopathy 10.2 TNF IL6 IL1B
60 acute necrotizing pancreatitis 10.2 TNF IL6 IL1B
61 muckle-wells syndrome 10.2 IL1B IL1A CXCL8
62 carbuncle 10.2 TNF IL6 IL1B
63 acute pericementitis 10.2 IL6 IL1B CXCL8
64 heart aneurysm 10.2 TNF IL6 IL1B
65 coronary aneurysm 10.2 TNF IL6 IL1B
66 diabetic encephalopathy 10.2 TNF IL6 IL1B
67 dilution, pigmentary 10.2
68 psoriasis 1 10.2
69 dowling-degos disease 1 10.2
70 psoriasis 2 10.2
71 psoriasis 7 10.2
72 psoriasis 11 10.2
73 fetal encasement syndrome 10.2
74 psoriasis 13 10.2
75 hereditary lymphedema i 10.2
76 neurotic disorder 10.2 TNF IL6 IL1B
77 gingival recession 10.2 TNF IL6 IL1B
78 alveolar periostitis 10.2 TNF IL6
79 subacute thyroiditis 10.2 TNF IL6 IL1B
80 aortic atherosclerosis 10.2 TNF IL6 IL1B
81 cerebral artery occlusion 10.2 TNF IL6 IL1B
82 suppurative periapical periodontitis 10.2 IL6 IL1B CXCL8
83 aspiration pneumonitis 10.2 TNF IL6 CXCL8
84 chronic recurrent multifocal osteomyelitis 10.2 TNF IL6 IL1B
85 cyclic neutropenia 10.2 TNF IL1B CXCL8
86 pleurisy 10.2 TNF IL1B CXCL8
87 pyoderma gangrenosum 10.2 TNF IL1B CXCL8
88 keratosis 10.2 LORICRIN KRT16 IVL FLG
89 back pain 10.2 IL6 IL1B CXCL8
90 cartilage disease 10.2 TNF IL6 IL1B
91 null-cell leukemia 10.2 TNF IL6
92 acute kidney tubular necrosis 10.2 TNF IL6 IL1B
93 nut allergy 10.2 IL4 IL13 FLG
94 pemphigus foliaceus 10.2 IL6 IL1B IL1A
95 persistent fetal circulation syndrome 10.2 TNF IL6 IL1B
96 retinal ischemia 10.2 TNF IL6 IL1B
97 rheumatic fever 10.2 TNF IL6 IL1A
98 endogenous depression 10.2 TNF IL6 IL1B
99 meconium aspiration syndrome 10.2 TNF IL6 CXCL8
100 intracranial hypertension 10.2 TNF IL6 IL1B
101 fuchs' heterochromic uveitis 10.2 IL6 CXCL8
102 mixed connective tissue disease 10.2 TNF IL6 IL1A
103 ureteral disease 10.2 TNF IL6 IL1B
104 pachyonychia congenita 1 10.2 LORICRIN KRT16 IVL FLG
105 carotid artery disease 10.2 TNF IL6 IL1B
106 bone deterioration disease 10.2 TNF IL6 IL1B
107 porokeratosis 10.2 LORICRIN KRT16 IVL FLG
108 blau syndrome 10.2 TNF IL4 IL1B
109 ischemic bone disease 10.2 TNF IL6 IL1B
110 cholesteatoma of middle ear 10.2 KRT16 IVL IL1A FLG
111 pulmonary artery disease 10.2 TNF IL6 CXCL8
112 infectious anterior uveitis 10.2 TNF IL17A
113 teeth hard tissue disease 10.2 TNF IL6 IL1B
114 epidermolysis bullosa simplex 10.2 LORICRIN KRT16 IVL FLG
115 bacterial meningitis 10.2 TNF IL1B CXCL8
116 urinary tract obstruction 10.2 TNF IL6 IL1B
117 trichuriasis 10.2 TNF IL13 CXCL8
118 epidermolytic hyperkeratosis 10.2 LORICRIN KRT16 IVL FLG
119 degeneration of macula and posterior pole 10.2 TNF IL6 IL1B
120 periodic fever, familial, autosomal dominant 10.1 TNF IL6 IL1B IL1A
121 adult-onset still's disease 10.1 TNF IL6 IL1B IL1A
122 bowen's disease 10.1 KRT16 IVL
123 adermatoglyphia 10.1 TNF LORICRIN IL6 IL1B
124 typhoid fever 10.1 TNF IL6 IL1B IL1A
125 non-alcoholic steatohepatitis 10.1 TNF IL6 IL1B
126 smallpox 10.1 TNF IL4 IL1B
127 papillary conjunctivitis 10.1 IL4 IL13 CXCL8
128 pulmonary alveolar proteinosis 10.1 TNF IL6 CXCL8
129 thunderstorm triggered asthma 10.1 IL4 IL13
130 acute generalized exanthematous pustulosis 10.1 IL17A CXCL8
131 bone structure disease 10.1 TNF IL6 IL1B
132 post-cardiac arrest syndrome 10.1 TNF IL6 IL1B CXCL8
133 autosomal recessive congenital ichthyosis 10.1 LORICRIN KRT16 IVL FLG
134 giant papillary conjunctivitis 10.1 IL4 IL13 CXCL8
135 anthracosis 10.1 TNF IL6 IL1B CXCL8
136 peptic esophagitis 10.1 TNF IL6 IL1B CXCL8
137 necrotizing fasciitis 10.1 TNF IL6 IL1B CXCL8
138 acute pyelonephritis 10.1 TNF IL6 IL1B CXCL8
139 photokeratitis 10.1 TAC1 IL6 IL1B
140 background diabetic retinopathy 10.1 TNF IL6 IL1B CXCL8
141 encephalomalacia 10.1 TNF IL6 IL1B CXCL8
142 intestinal benign neoplasm 10.1 TNF IL6 IL1B
143 poems syndrome 10.1 TNF IL6 IL1B CXCL8
144 periventricular leukomalacia 10.1 TNF IL6 IL1B CXCL8
145 vitreous disease 10.1 TNF IL6 IL1B CXCL8
146 pyelitis 10.1 TNF IL6 IL1B CXCL8
147 retinal vascular occlusion 10.1 TNF IL6 IL1B CXCL8
148 dengue shock syndrome 10.1 TNF IL6 IL1B CXCL8
149 macular retinal edema 10.1 TNF IL6 IL1B CXCL8
150 leukostasis 10.1 TNF IL6 IL1B CXCL8
151 diabetic macular edema 10.1 TNF IL6 IL1B CXCL8
152 mental depression 10.1 TNF IL6 IL1B
153 fabry disease 10.1 TNF IL6 IL1B IL1A
154 glossitis 10.1 TNF KRT16 IL6 IL1B
155 endometritis 10.1 TNF IL6 IL1B CXCL8
156 opisthorchiasis 10.1 TNF IL4 IL1B CXCL8
157 peptic ulcer disease 10.1 TNF IL6 IL1B CXCL8
158 leukemia, acute monocytic 10.1 TNF IL6 IL1B CXCL8
159 pericarditis 10.1 TNF IL6 IL1B CXCL8
160 lymphadenitis 10.1 TNF IL6 IL1B CXCL8
161 duodenal ulcer 10.1 TNF IL6 IL1B CXCL8
162 inflammatory diarrhea 10.1 IL1B IL17A CXCL8
163 sapho syndrome 10.1 TNF IL17A CXCL8
164 pancreatitis 10.1 TNF IL6 IL1B CXCL8
165 gingival overgrowth 10.1 TNF IL6 IL1A CXCL8
166 lens disease 10.1 TNF IL6 IL1B CXCL8
167 critical illness polyneuropathy 10.1 TNF IL6
168 toxocariasis 10.1 IL6 IL4 IL13
169 oculodentodigital dysplasia 10.1
170 root resorption 10.1 IL6 IL4 IL1B IL1A
171 alcoholic hepatitis 10.1 TNF IL6 IL1B CXCL8
172 persistent severe asthma 10.1 TSLP IL4 IL13
173 pustulosis of palm and sole 10.1 TNF IL17A CXCL8
174 retinal vascular disease 10.1 TNF IL6 IL1B CXCL8
175 exudative vitreoretinopathy 1 10.1 TNF IL6 IL1B CXCL8
176 pemphigus vulgaris, familial 10.1 IVL IL1A CCL17
177 bronchiectasis 10.1 TNF IL6 IL1B CXCL8
178 placenta disease 10.1 TNF IL6 IL1B CXCL8
179 intracranial berry aneurysm 10.1 TNF IL6 IL1B CXCL8
180 near-fatal asthma 10.1 TSLP IL4 IL13
181 thrombocytosis 10.1 IL6 IL1B IL1A
182 keratopathy 10.1 TAC1 IL6 CXCL8
183 scrub typhus 10.1 TNF IL1B IL17A
184 varicose veins 10.1 TNF IL6 CXCL8
185 alcohol dependence 10.1
186 vitiligo-associated multiple autoimmune disease susceptibility 6 10.1
187 acrodermatitis enteropathica, zinc-deficiency type 10.1
188 alopecia universalis congenita 10.1
189 hypoascorbemia 10.1
190 ceroid lipofuscinosis, neuronal, 5 10.1
191 wiskott-aldrich syndrome 10.1
192 glass syndrome 10.1
193 helix syndrome 10.1
194 latex allergy 10.1
195 venous insufficiency 10.1
196 osteonecrosis 10.1
197 leech infestation 10.1
198 tinea manuum 10.1
199 capillary lymphangioma 10.1
200 hypertrichosis 10.1
201 dermatographia 10.1
202 pellagra 10.1
203 impetigo 10.1
204 alopecia totalis 10.1
205 cytokine deficiency 10.1
206 laugier-hunziker syndrome 10.1
207 lip and oral cavity cancer 10.1
208 pyogenic granuloma 10.1
209 paresthesia 10.1
210 syncope 10.1
211 progressive non-infectious anterior vertebral fusion 10.1
212 rare lymphatic malformation 10.1
213 bullous impetigo 10.1
214 q fever 10.1 TNF IL6 IL4 IL1B
215 acute pancreatitis 10.1 TNF IL6 IL1B CXCL8
216 gout 10.1 TNF IL6 IL1B CXCL8
217 aortic aneurysm, familial abdominal, 1 10.1 TNF IL6 IL1B CXCL8
218 aortic aneurysm 10.1 TNF IL6 IL1B CXCL8
219 toxic encephalopathy 10.1 TNF IL6 IL1B
220 fatty liver disease 10.1 TNF IL6 IL1B IL1A
221 narcolepsy 10.1 TNF IL6 IL1B IL1A
222 rubella 10.1 TNF IL6 IL4 IL1B
223 adult respiratory distress syndrome 10.1 TNF IL6 IL1B CXCL8
224 keratoconjunctivitis 10.1 TNF IL4 IL1A IL13
225 pulmonary edema 10.1 TNF IL1B IL13 CXCL8
226 epidermolysis bullosa 10.1 LORICRIN KRT16 IVL FLG CXCL8
227 vulvovaginal candidiasis 10.1 IL4 IL1B IL17A
228 acquired metabolic disease 10.1 TNF IL6 IL1B CXCL8
229 uremia 10.1 TNF IL6 IL1B
230 vernal keratoconjunctivitis 10.1 IL4 IL13
231 keratoconus 10.1 TNF IL6 IL1B IL1A
232 carpal tunnel syndrome 10.0 TAC1 IL6 IL1B
233 atherosclerosis susceptibility 10.0 TNF IL6 IL1B CXCL8
234 vascular dementia 10.0 TNF IL6 IL1B
235 funisitis 10.0 TNF IL6 IL1B IL1A CXCL8
236 synovitis 10.0 TNF IL6 IL1B IL1A CXCL8
237 cough variant asthma 10.0 TAC1 IL4 IL13
238 endometrial disease 10.0 TNF IL6 IL1B IL1A CXCL8
239 pulpitis 10.0 TNF IL6 IL1B IL1A CXCL8
240 hidradenitis 10.0 TNF IL1B IL1A IL17A
241 hidradenitis suppurativa 10.0 TNF IL1B IL1A IL17A
242 preterm premature rupture of the membranes 10.0 TNF IL6 IL1B IL1A CXCL8
243 severe combined immunodeficiency, x-linked 10.0 TSLP IL4 IL13
244 alcoholic liver cirrhosis 10.0 TNF IL6 IL1B IL1A CXCL8
245 frozen shoulder 10.0 TNF TAC1 IL6 IL1B
246 pneumoconiosis 10.0 TNF IL6 IL1B IL1A CXCL8
247 vasomotor rhinitis 10.0 TAC1 IL4 IL13
248 bursitis 10.0 TNF TAC1 IL6 IL1B
249 chronic rhinitis 10.0 TAC1 IL4 IL13
250 interstitial cystitis 10.0 TNF TAC1 IL6 IL1B
251 spondylosis 10.0 TNF TAC1 IL6 IL1B
252 complex regional pain syndrome 10.0 TNF TAC1 IL6 IL1B
253 corneal ulcer 10.0 TNF TAC1 IL6 IL1B
254 diphtheria 10.0 TNF IL4 IL1B IL13
255 autonomic nervous system disease 10.0 TNF TAC1 IL6 IL1B
256 molluscum contagiosum 10.0 TNF LORICRIN IVL FLG CCL27
257 pain agnosia 10.0 TNF TAC1 IL6 IL1B
258 agnosia 10.0 TNF TAC1 IL6 IL1B
259 chromium allergic contact dermatitis 10.0 IL4 IL17A IL13
260 neutrophilic dermatosis, acute febrile 10.0 TNF IL1B IL17A CXCL8
261 esophagitis, eosinophilic, 1 10.0 TSLP IL4 IL13 FLG
262 pyoderma 10.0 TNF IL1B IL17A CXCL8
263 filariasis 10.0 TNF IL6 IL4 IL13
264 diverticulitis 10.0 TNF IL6 CXCL10
265 chemical colitis 10.0 TNF IL6 IL1B IL17A
266 urethral syndrome 10.0 TNF TAC1 IL6 CXCL8
267 type 1 diabetes mellitus 23 10.0 TNF CD4
268 crohn's colitis 10.0 TNF IL6 IL1B IL17A
269 myelitis 10.0 TNF IL6 IL17A CXCL8
270 endometriosis 10.0 IL6 IL1B IL1A CXCL8
271 cholangitis 10.0 TNF IL6 IL17A CXCL8
272 exercise-induced bronchoconstriction 10.0 TSLP IL4 IL13 CXCL8
273 keratoacanthoma 10.0 KRT16 IVL FLG
274 inflammatory bowel disease 1 10.0 TNF IL6 IL1B IL17A
275 specific developmental disorder 10.0 TNF TAC1 IL6 IL1B
276 spondylitis 10.0 TNF IL6 IL1B IL17A
277 cervical adenitis 10.0 TNF IL1B CD4
278 lyme disease 10.0 TNF IL6 IL1B IL17A
279 chikungunya 10.0 TNF IL6 IL1B IL17A
280 chronic spontaneous urticaria 10.0 TSLP IL4 IL31 IL13
281 pericardial tuberculosis 10.0 TNF CD4
282 acute cervicitis 10.0 CXCL8 CD4
283 congenital toxoplasmosis 10.0 TNF IL1B CD4
284 fibromyalgia 10.0 TNF IL6 IL4 IL1B CXCL8
285 gastroenteritis 10.0 TNF IL6 IL4 IL1B CXCL8
286 pulmonary sarcoidosis 10.0 TNF IL6 CXCL10
287 common variable immunodeficiency 10.0 TNF IL6 IL4 IL1B IL1A
288 cholera 9.9 TNF IL6 IL4 IL1B CXCL8
289 body mass index quantitative trait locus 1 9.9
290 celiac disease 5 9.9
291 immunodeficiency, common variable, 10 9.9
292 cutaneous candidiasis 9.9
293 low compliance bladder 9.9
294 paronychia 9.9
295 spinal cord injury 9.9
296 ige responsiveness, atopic 9.9
297 rhabdomyosarcoma 2 9.9
298 fanconi anemia, complementation group e 9.9
299 basal cell carcinoma 1 9.9
300 intraocular pressure quantitative trait locus 9.9
301 basal cell carcinoma 9.9
302 48,xxxy syndrome 9.9
303 48,xxyy syndrome 9.9
304 48,xyyy 9.9
305 gastroesophageal reflux 9.9 TNF IL6 IL4 IL1B CXCL8
306 trachoma 9.9 TNF IL6 IL4 IL17A
307 viral exanthem 9.9 TNF IL6 CD4
308 pleural tuberculosis 9.9 TNF CXCL8 CD4
309 neutropenia 9.9 TNF IL6 IL4 IL1B CXCL8
310 superficial basal cell carcinoma 9.9 TNF IL6 CD4
311 bell's palsy 9.9 TNF IL6 CD4
312 relapsing polychondritis 9.9 TNF IL6 CD4
313 bacillary angiomatosis 9.9 CXCL8 CD4
314 ichthyosis 9.9 LORICRIN KRT16 IVL IL17A FLG
315 miliary tuberculosis 9.9 TNF IL4 CD4
316 glomerulonephritis 9.9 TSLP TNF IL6 IL4 IL1B
317 croup 9.9 IL6 CXCL8 CD4
318 transverse myelitis 9.9 TNF IL6 CD4
319 neurosyphilis 9.9 IL17A CXCL8 CXCL10
320 facial nerve disease 9.9 TNF IL6 CD4
321 tuberculoid leprosy 9.9 TNF IL4 CD4
322 facial paralysis 9.9 TNF IL6 CD4
323 dental pulp disease 9.9 TNF TAC1 IL6 IL1B CXCL8
324 intestinal perforation 9.9 TNF IL6 CD4
325 burning mouth syndrome 9.9 TNF TAC1 IL6 IL1B CXCL8
326 anogenital venereal wart 9.9 TNF IL6 CD4
327 pemphigus 9.9 TNF IL6 IL4 IL17A
328 somatoform disorder 9.9 TNF TAC1 IL6 IL1B CXCL8
329 disseminated intravascular coagulation 9.9 TNF IL6 CXCL10
330 mucormycosis 9.9 TNF IL6 CD4
331 hypersensitivity reaction type iii disease 9.9 TNF IL6 CD4
332 paine syndrome 9.9 TNF TAC1 IL6 IL1B CXCL8
333 capillary disease 9.9 TNF IL6 CD4
334 henoch-schoenlein purpura 9.9 TNF IL6 CD4
335 sleep disorder 9.9 TNF TAC1 IL6 IL1B CXCL8
336 ileus 9.9 TNF IL6 IL1B IL1A IL17A
337 poliomyelitis 9.9 TNF IL6 CD4
338 sleep apnea 9.9 TNF TAC1 IL6 IL1B CXCL8
339 chronic meningitis 9.9 IL1B IL13 CD4
340 demyelinating polyneuropathy 9.9 TNF IL6 CD4
341 anus disease 9.9 TNF IL6 CD4
342 palladium allergic contact dermatitis 9.9 TNF IL1B IL17A CCL17
343 lepromatous leprosy 9.9 TNF IL4 CD4
344 eosinophilic pneumonia 9.9 IL4 IL13 CXCL8 CCL17
345 pulmonary eosinophilia 9.9 IL4 IL13 CXCL8 CCL17
346 hepatic vascular disease 9.9 TNF IL6 CD4
347 leptospirosis 9.9 TNF IL6 IL4 IL1B IL1A CXCL8
348 subacute sclerosing panencephalitis 9.9 TNF IL6 IL4 CXCL10
349 tonsillitis 9.9 TNF IL6 IL4 IL1B IL1A CXCL8
350 pericardial effusion 9.9 TNF IL6 CD4
351 chorioamnionitis 9.9 TNF IL6 IL4 IL1B IL1A CXCL8
352 gingivitis 9.9 TNF IL6 IL4 IL1B IL1A CXCL8
353 toxic shock syndrome 9.9 TNF IL6 IL4 IL1B IL1A CXCL8
354 endocarditis 9.9 TNF IL6 IL1A IL17A CXCL8
355 cowpox 9.9 IL6 CXCL8 CD4
356 mastitis 9.9 IL6 IL17A CXCL8
357 blood protein disease 9.9 TNF IL6 CD4
358 vasculitis 9.9 TNF IL6 IL1B IL17A CXCL8
359 rosacea 9.9 TNF IL6 IL1B IL17A CXCL8
360 appendicitis 9.9 TNF IL6 IL1B IL17A CXCL8
361 elephantiasis 9.9 IL4 IL13 CD4
362 retinal detachment 9.9 TNF IL6 CXCL8 CXCL10
363 limited scleroderma 9.9 TNF IL6 CD4
364 chancroid 9.9 CXCL8 CD4 CCL27
365 sialadenitis 9.9 TNF IL13 CD4
366 migraine with or without aura 1 9.9 TNF TAC1 IL6 IL1B CXCL8
367 peritonitis 9.9 TNF IL6 IL1B IL17A CXCL8
368 pulmonary fibrosis 9.9 IL1B IL13 CXCL8 CCL17
369 erythema nodosum 9.8 TNF IL6 IL1B IL1A IL13 CXCL8
370 blepharoconjunctivitis 9.8 IL4 IL13 CD4
371 cow milk allergy 9.8 IL4 IL13 CD4
372 testicular disease 9.8 TNF IL6 CD4
373 t2-high asthma 9.8 TSLP IL4 IL17A IL13
374 mikulicz disease 9.8 IL4 IL13 CD4
375 ascaris lumbricoides infection 9.8 IL4 IL13 CD4
376 chronic eosinophilic pneumonia 9.8 IL6 IL13 CD4
377 cerebritis 9.8 TNF IL6 IL1B CD4
378 chondromalacia 9.8 TNF IL6 IL1B CD4
379 lung abscess 9.8 TNF IL6 IL1B CD4
380 hypereosinophilic syndrome 9.8 IL4 IL13 CXCL8 CCL17
381 scarlet fever 9.8 TNF IL6 IL1B CD4
382 hemorrhagic cystitis 9.8 TNF IL6 IL1B CD4
383 urinary schistosomiasis 9.8 IL4 IL13 CD4
384 keratoconjunctivitis sicca 9.8 TNF IL4 IL1A CD4
385 pollen allergy 9.8 IL4 IL13 CD4
386 acute myocarditis 9.8 TNF IL6 IL1B CD4
387 necrotizing ulcerative gingivitis 9.8 IL6 IL1B CXCL8 CD4
388 igg4-related disease 9.8 IL4 IL13 CD4
389 anxiety 9.8 TNF TAC1 IL6 IL1B CXCL8
390 legionellosis 9.8 TNF IL6 IL1B CD4
391 strongyloidiasis 9.8 IL4 IL13 CD4
392 rheumatic heart disease 9.8 TNF IL6 IL4 IL1B IL17A
393 legionnaire disease 9.8 TNF IL6 IL1B CD4
394 drug allergy 9.8 IL4 IL13 CD4
395 echinococcosis 9.8 TNF IL6 IL17A CCL17
396 toxoplasmosis 9.8 TNF IL6 IL4 IL1B IL17A
397 dermatitis herpetiformis 9.8 TNF IL4 IL31 IL17A CXCL8
398 encephalitis 9.8 TNF IL6 IL1B CXCL8 CXCL10
399 myelofibrosis 9.8 TNF IL1B IL17A CXCL8
400 non-severe covid-19 9.8 TNF IL6 CXCL8 CD4
401 swine influenza 9.8 TNF IL6 CXCL8 CD4
402 syphilis 9.8 TNF IL17A CD4
403 tracheal disease 9.8 TNF IL6 CXCL8 CD4
404 cranial nerve disease 9.8 TNF IL6 IL1B CD4
405 optic papillitis 9.8 TNF CD4
406 granuloma annulare 9.8 TNF IL17A CD4
407 retinal vein occlusion 9.8 TNF IL6 IL1B CXCL8 CXCL10
408 idiopathic interstitial pneumonia 9.8 TNF IL6 CXCL8 CD4
409 pneumonic plague 9.8 TNF IL17A CD4
410 optic neuritis 9.8 TNF IL6 IL1B CXCL8 CXCL10
411 plasma protein metabolism disease 9.8 TNF IL6 CXCL8 CD4
412 sympathetic ophthalmia 9.8 TNF IL17A CD4
413 substance abuse 9.8 TNF IL6 IL1B CD4
414 alcohol use disorder 9.8 TNF IL6 IL1B CD4
415 collagenous colitis 9.8 TNF IL17A CD4
416 tetanus 9.8 TNF IL6 IL4 IL1B IL1A IL13
417 mumps 9.8 TNF IL6 IL1B CXCL8 CXCL10
418 dengue disease 9.8 TNF IL6 CXCL8 CD4
419 choroiditis 9.8 TNF IL17A CD4
420 schistosomiasis 9.8 TNF IL4 IL1A IL17A IL13
421 pulmonary tuberculosis 9.8 TNF IL6 IL4 IL1B CXCL10
422 birdshot chorioretinopathy 9.8 TNF IL17A CD4
423 crescentic glomerulonephritis 9.8 TNF IL17A CD4
424 autoimmune disease of urogenital tract 9.8 TNF IL17A CD4
425 graves' disease 9.8 IL4 IL1A IL13 CXCL10
426 cysticercosis 9.8 IL6 IL4 IL1B CD4
427 acquired immunodeficiency syndrome 9.8 TNF IL6 IL1B CD4
428 bronchiolitis obliterans 9.8 TNF IL6 IL17A IL13 CXCL8
429 progressive multifocal leukoencephalopathy 9.8 TNF IL17A CD4
430 external ear disease 9.8 IL6 IL17A CD4
431 adenoid hypertrophy 9.8 IL6 IL4 CXCL8 CD4
432 nasopharyngitis 9.8 TNF IL6 IL31 IL17A IL13
433 thyroiditis 9.8 TNF IL6 IL4 IL1B CXCL10
434 salivary gland disease 9.8 TNF IL6 IL4 CD4
435 asymptomatic neurosyphilis 9.8 CXCL10 CD4
436 cryoglobulinemia 9.8 TSLP TNF IL6 IL1B CXCL10
437 hyper ige recurrent infection syndrome 1 9.8 IL6 IL17A CD4
438 paracoccidioidomycosis 9.8 TNF IL6 IL4 CXCL8 CXCL10
439 arachnoiditis 9.8 TNF TAC1 IL1B CD4
440 silicosis 9.8 TNF IL4 IL1B IL1A IL17A CXCL8
441 leptin deficiency or dysfunction 9.8 TNF IL6 IL1B CD4
442 cerebral palsy 9.8 TNF IL6 IL4 IL1B IL13 CXCL8
443 osteoarthritis 9.8 TNF IL6 IL1B IL1A IL17A CXCL8
444 giardiasis 9.8 IL6 IL17A CD4
445 churg-strauss syndrome 9.8 TNF IL1B IL17A CXCL8 CCL17
446 mucocutaneous leishmaniasis 9.7 TNF IL4 IL13 CD4
447 glucose metabolism disease 9.7 TNF IL6 IL1B CD4
448 filarial elephantiasis 9.7 TNF IL4 IL13 CD4
449 carbohydrate metabolic disorder 9.7 TNF IL6 IL1B CD4
450 genital herpes 9.7 TNF CXCL10 CD4
451 oral candidiasis 9.7 IL6 IL17A CD4
452 childhood type dermatomyositis 9.7 TNF CXCL10 CD4
453 esophageal candidiasis 9.7 IL17A IL13 CD4
454 t cell deficiency 9.7 IL4 IL17A CD4
455 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.7 IL4 IL17A CD4
456 juvenile rheumatoid arthritis 9.7 TNF IL6 IL1B IL1A CD4
457 t2-low asthma 9.7 TSLP IL4 IL17A IL13 CXCL8
458 pneumonic tularemia 9.7 TNF IL1B IL17A CD4
459 extrinsic allergic alveolitis 9.7 TNF IL6 IL1A CXCL8 CD4
460 pyelonephritis 9.7 TNF IL6 IL1B IL1A CXCL8 CXCL10
461 bacterial conjunctivitis 9.7 TNF IL6 IL1B CXCL8 CD4
462 tracheitis 9.7 TNF IL6 IL1B CXCL8 CD4
463 trichomoniasis 9.7 TNF IL6 IL1B CXCL8 CD4
464 acute proliferative glomerulonephritis 9.7 TNF IL1B IL17A CD4
465 salpingitis 9.7 TNF IL6 IL1B CXCL8 CD4
466 urethritis 9.7 TNF IL6 IL1B CXCL8 CD4
467 epididymis disease 9.7 TNF IL6 IL1B CXCL8 CD4
468 blood group, globoside system 9.7 TNF IL6 IL1B CXCL8 CD4
469 pharyngitis 9.7 TNF IL6 IL1B CXCL8 CD4
470 cervicitis 9.7 TNF IL6 IL1B CXCL8 CD4
471 cecal disease 9.7 TNF IL6 IL1B CXCL8 CD4
472 endophthalmitis 9.7 TNF IL6 IL1B CXCL8 CD4
473 fallopian tube disease 9.7 TNF IL6 IL1B CXCL8 CD4
474 mononeuropathy 9.7 TNF TAC1 IL6 CD4
475 aseptic meningitis 9.7 TNF IL6 IL1B CXCL8 CD4
476 pericardium disease 9.7 TNF IL6 IL1B CXCL8 CD4
477 non-alcoholic fatty liver disease 9.7 TNF IL6 IL1B CXCL8 CXCL10
478 endocardium disease 9.7 TNF IL6 IL1B CXCL8 CD4
479 vein disease 9.7 TNF IL6 IL1B CXCL8 CD4
480 purpura 9.7 TNF IL6 IL4 IL1B IL17A CXCL8
481 pleural disease 9.7 TNF IL6 IL1B CXCL8 CD4
482 blood coagulation disease 9.7 TNF IL6 IL1B CXCL8 CD4
483 relapsing-remitting multiple sclerosis 9.7 TNF IL6 IL4 IL1B IL17A CXCL8
484 gastritis 9.7 TNF IL6 IL4 IL1B IL17A CXCL8
485 blood platelet disease 9.7 TNF IL6 IL1B CXCL8 CD4
486 bilirubin metabolic disorder 9.7 TNF IL6 IL1B CXCL8 CD4
487 skin sarcoidosis 9.7 TNF IL6 IL17A CD4
488 angular cheilitis 9.7 TNF IL6 IL17A CD4
489 sensory system disease 9.7 TNF IL6 IL1B CXCL8 CD4
490 blastomycosis 9.7 TNF IL6 IL17A CD4
491 iritis 9.7 TNF IL6 IL17A CD4
492 good syndrome 9.7 TNF IL6 IL17A CD4
493 autoimmune vasculitis 9.7 TNF IL6 IL17A CD4
494 herpangina 9.7 TNF IL6 IL4 IL1B CD4
495 intermediate uveitis 9.7 TNF IL6 IL17A CD4
496 eczema herpeticum 9.7 TSLP LORICRIN IVL IL4 IL31 IL13
497 west nile encephalitis 9.7 TNF IL6 IL4 IL1B CD4
498 milk allergy 9.7 TSLP IL4 IL13 CD4
499 acne 9.7 TNF IL6 IL1B IL1A IL17A FLG
500 listeriosis 9.7 TNF IL6 IL4 IL1B CD4
501 plague 9.7 TNF IL6 IL4 IL1B CD4
502 pneumocystosis 9.7 TNF IL6 IL17A CD4
503 human cytomegalovirus infection 9.7 TNF IL6 IL17A CD4
504 invasive aspergillosis 9.7 TNF IL6 IL17A CD4
505 autoimmune disease of peripheral nervous system 9.7 TNF IL6 IL17A CD4
506 vogt-koyanagi-harada disease 9.7 TNF IL6 IL17A CD4
507 radiculopathy 9.7 TAC1 IL6 IL17A IL13 CXCL8
508 nail disease 9.7 TNF IL6 IL17A CD4
509 short syndrome 9.7 TNF IL6 IL17A CD4
510 pre-eclampsia 9.7 TNF IL6 IL4 IL1B IL17A CXCL8
511 ileitis 9.7 TNF IL6 IL17A CD4
512 sclerosing cholangitis 9.7 TNF IL6 IL17A CD4
513 middle east respiratory syndrome 9.7 IL6 CXCL10 CD4
514 folliculitis 9.7 TNF IL4 IL17A CD4
515 actinic keratosis 9.7 TNF LORICRIN IVL IL6 FLG CD4
516 neuritis 9.7 TNF IL6 IL4 IL1B CXCL8 CXCL10
517 cutaneous leishmaniasis 9.6 TNF IL4 IL1A IL13 CD4
518 brucellosis 9.6 TNF IL6 IL4 IL17A IL13 CXCL8
519 neuromyelitis optica 9.6 IL6 IL4 IL1B IL17A CXCL10
520 vaginal discharge 9.6 TNF IL6 IL1B IL1A CXCL8 CD4
521 bacterial vaginosis 9.6 TNF IL6 IL1B IL1A CXCL8 CD4
522 dysentery 9.6 TNF IL6 IL1B IL1A CXCL8 CD4
523 periodontitis 9.6 TNF IL6 IL4 IL1B IL1A IL17A
524 chlamydia 9.6 TNF IL6 IL4 IL1B IL1A IL17A
525 hyper ige syndrome 9.6 IL6 IL4 IL17A CD4
526 familial mediterranean fever 9.6 TNF IL6 IL4 IL1B IL1A IL17A
527 sudden infant death syndrome 9.6 TNF TAC1 IL6 IL1B IL1A IL13
528 egg allergy 9.6 TSLP IL4 IL13 FLG CD4
529 legume allergy 9.6 TSLP IL4 IL13 FLG CD4
530 fruit allergy 9.6 TSLP IL4 IL13 FLG CD4
531 peanut allergy 9.6 TSLP IL4 IL13 FLG CD4
532 granulomatosis with polyangiitis 9.6 TNF IL17A IL13 CD4
533 dacryoadenitis 9.6 IL4 IL17A IL13 CD4
534 intestinal schistosomiasis 9.6 IL4 IL17A IL13 CD4
535 allergic bronchopulmonary aspergillosis 9.6 IL4 IL13 CD4 CCL17
536 speech and communication disorders 9.6 TNF TAC1 IL6 IL1B CD4
537 cystitis 9.6 TNF TAC1 IL6 IL4 IL17A CXCL8
538 transient arthritis 9.6 TNF IL6 IL1B IL17A CD4
539 disease of mental health 9.6 TNF TAC1 IL6 IL1B CD4
540 hypopyon 9.6 TNF IL6 IL1B IL17A CD4
541 tenosynovitis 9.6 TNF IL6 IL1B IL17A CD4
542 aortitis 9.6 TNF IL6 IL1B IL17A CD4
543 scleral disease 9.6 TNF IL6 IL1B IL17A CD4
544 microscopic colitis 9.6 TNF IL6 IL1B IL17A CD4
545 tularemia 9.6 TNF IL6 IL1B IL17A CD4
546 central nervous system vasculitis 9.6 TNF IL6 IL1B IL17A CD4
547 orchitis 9.6 TNF IL6 IL1B IL17A CD4
548 constipation 9.6 TNF TAC1 IL6 IL1B CD4
549 panuveitis 9.6 TNF IL6 IL1B IL17A CD4
550 myositis 9.6 TNF IL6 IL1B IL1A IL17A CXCL10
551 thyroid gland disease 9.6 TNF IL6 CD4
552 intermittent asthma 9.6 TSLP IL4 IL13 CXCL8 CD4
553 occupational asthma 9.6 TSLP IL4 IL13 CXCL8 CD4
554 environmental induced asthma 9.6 TSLP IL4 IL13 CXCL8 CD4
555 spondyloarthropathy 1 9.6 TNF IL6 IL1B IL17A CD4
556 osteomyelitis 9.6 TNF IL6 IL4 IL1B IL1A CXCL8
557 norwegian scabies 9.6 IL17A IL13 CD4 CCL27
558 aplastic anemia 9.6 TNF IL6 IL4 IL1B IL1A CD4
559 optic nerve disease 9.6 TNF IL6 IL1B IL17A CD4
560 myelodysplastic syndrome 9.6 TNF IL6 IL1B IL1A CXCL8 CD4
561 chronic fatigue syndrome 9.6 TNF IL6 IL4 IL1B CXCL8 CD4
562 osteoporosis 9.6 TNF IL6 IL4 IL1B IL1A IL17A
563 breast adenocarcinoma 9.5 TNF IL6 IL4 IL1B CXCL8 CD4
564 lung disease 9.5 TNF IL6 IL1B IL1A IL13 CXCL8
565 yellow fever 9.5 IL6 IL4 IL1B IL1A IL17A CXCL10
566 myocardial infarction 9.5 TNF IL6 IL4 IL1B IL1A IL17A
567 fungal meningitis 9.5 TNF IL6 IL4 IL17A CD4
568 cryptococcal meningitis 9.5 TNF IL6 IL4 IL17A CD4
569 viral encephalitis 9.5 TNF IL6 IL1B CXCL10 CD4
570 eyelid disease 9.5 TNF IL6 IL4 IL17A CD4
571 autoimmune disease of blood 9.5 TNF IL6 IL4 IL17A CD4
572 ebola hemorrhagic fever 9.5 TNF IL6 IL1B CXCL10 CD4
573 primary progressive multiple sclerosis 9.5 TNF IL6 IL4 IL17A CD4
574 b cell deficiency 9.5 TNF IL6 IL4 IL17A CD4
575 chronic mucocutaneous candidiasis 9.5 IL6 IL4 IL1B IL17A CD4
576 esophagitis 9.5 TSLP TNF IL6 IL4 IL1B IL13
577 hantavirus hemorrhagic fever with renal syndrome 9.5 TNF IL6 CXCL8 CXCL10 CD4
578 ulcerative colitis 9.5 TNF IL6 IL4 IL1B IL17A IL13
579 dengue hemorrhagic fever 9.5 TNF IL6 CXCL8 CXCL10 CD4
580 hepatitis a 9.5 TNF IL4 IL1B CXCL10 CD4
581 viral meningitis 9.5 TNF IL6 CXCL8 CXCL10 CD4
582 posterior uveitis 9.5 TNF IL6 IL17A IL13 CD4
583 hair disease 9.5 TNF LORICRIN IL6 IL17A FLG CD4
584 aspiration pneumonia 9.5 TNF TAC1 IL6 IL1B CXCL8 CD4
585 cryptococcosis 9.5 TNF IL4 IL17A IL13 CD4
586 irritable bowel syndrome 9.5 TNF TAC1 IL6 IL4 IL1B IL17A
587 spinal cord disease 9.5 TNF IL6 CD4
588 severe combined immunodeficiency 9.5 TNF IVL IL6 IL4 IL13 CD4
589 mite infestation 9.5 TSLP IL4 IL31 IL13 FLG CD4
590 laryngitis 9.5 TNF IL6 IL4 IL1B IL1A CXCL8
591 periapical periodontitis 9.5 TNF IL6 IL1B IL1A IL17A CXCL8
592 cryptosporidiosis 9.5 TNF TAC1 IL1A CXCL10 CD4
593 iridocyclitis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
594 septic arthritis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
595 aphthous stomatitis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
596 anterior uveitis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
597 cellulitis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
598 perinatal necrotizing enterocolitis 9.5 TNF IL6 IL1B IL17A CXCL8 CD4
599 allergic asthma 9.5 TSLP IL4 IL17A IL13 CXCL8 CCL17
600 keratitis, hereditary 9.4 TNF IL6 IL1B IL17A CXCL8 CD4
601 colonic benign neoplasm 9.4 TNF IL6 IL1B IL17A CXCL8 CD4
602 leukemia, acute myeloid 9.4 TNF IL6 IL4 IL1B CXCL8 CD4
603 sezary's disease 9.4 IL4 IL31 CD4 CCL27 CCL17
604 seborrheic dermatitis 9.4 TNF LORICRIN IL1A IL17A FLG CXCL8
605 interstitial lung disease 9.4 TNF IL6 IL4 IL1B IL1A IL13
606 aggressive periodontitis 9.4 TNF IL6 IL4 IL1B IL1A IL17A
607 leishmaniasis 9.4 TNF IL6 IL4 IL1B IL1A IL17A
608 meningitis 9.4 TNF IL6 IL4 IL1B IL1A IL17A
609 otitis media 9.4 TNF IL6 IL4 IL1B IL1A IL17A
610 primary systemic mycosis 9.4 TNF IL6 IL4 IL1B IL17A CD4
611 arthritis 9.4 TNF IL6 IL4 IL1B IL1A IL17A
612 autoimmune myocarditis 9.4 TNF IL6 IL4 IL1B IL17A CD4
613 autoimmune disease of eyes, ear, nose and throat 9.4 TNF IL6 IL4 IL1B IL17A CD4
614 autoimmune uveitis 9.4 TNF IL6 IL4 IL1B IL17A CD4
615 chickenpox 9.4 TNF IL6 IL4 IL1B IL17A CD4
616 autoimmune disease of exocrine system 9.4 TNF IL6 IL4 IL1B IL17A CD4
617 splenic disease 9.4 TNF IL6 IL4 IL1B IL17A CD4
618 upper respiratory tract disease 9.4 TSLP TNF IL6 IL4 IL13 CD4
619 diamond-blackfan anemia 1 9.4 TNF IL6 IL4 IL1B IL17A CD4
620 autoimmune disease of endocrine system 9.4 TNF IL6 IL4 IL1B IL17A CD4
621 heart disease 9.4 TNF IL6 IL4 IL1B IL1A IL17A
622 demyelinating disease 9.4 TNF IL6 IL4 IL1B IL17A CD4
623 mycoplasma pneumoniae pneumonia 9.4 TNF IL6 IL4 IL17A CXCL8 CD4
624 long covid 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
625 critical covid-19 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
626 viral pneumonia 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
627 bacterial sepsis 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
628 avian influenza 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
629 amyotrophic lateral sclerosis 1 9.4 TNF IL6 IL4 IL1B IL1A CXCL8
630 hemophagocytic lymphohistiocytosis 9.4 TNF IL6 IL1B CXCL8 CXCL10 CD4
631 psoriatic arthritis 9.4 TNF IL6 IL1B IL1A IL17A IL13
632 severe acute respiratory syndrome 9.4 TNF IL6 IL4 IL1B IL17A CXCL8
633 neurodermatitis 9.4 TSLP TAC1 IL4 IL31 IL13 FLG
634 allergic rhinitis 9.4 TAC1 IL4 IL17A IL13 CXCL8 CCL17
635 taeniasis 9.4 TNF TAC1 IL6 IL4 IL13 CD4
636 lichen planus 9.4 TNF KRT16 IVL IL6 IL4 IL1B
637 type 1 diabetes mellitus 9.4 TNF IL6 IL4 IL1B IL17A CXCL8
638 bacterial infectious disease 9.4 TNF IL6 IL1B IL1A IL17A CXCL8
639 vaginitis 9.4 TNF IL6 IL1B IL1A IL17A CXCL8
640 vaginal disease 9.4 TNF IL6 IL1B IL1A IL17A CXCL8
641 tendinitis 9.4 TNF TAC1 IL6 IL1B IL17A CD4
642 localized scleroderma 9.3 TNF IL6 IL4 IL17A IL13 CD4
643 lymphoid interstitial pneumonia 9.3 TNF IL6 IL4 IL17A IL13 CD4
644 meningoencephalitis 9.3 TNF TAC1 IL6 IL1B CXCL10 CD4
645 prostatitis 9.3 TNF IL6 IL4 IL1B IL1A IL17A
646 aspergillosis 9.3 TNF IL6 IL4 IL1B IL1A CXCL8
647 uveitis 9.3 TNF IL6 IL4 IL1B IL1A IL17A
648 metal allergy 9.3 TNF IL4 IL1B IL17A IL13 FLG
649 amebiasis 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
650 lichen disease 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
651 rectal disease 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
652 middle ear disease 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
653 spondyloarthropathy 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
654 autoimmune disease of cardiovascular system 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
655 hypersensitivity reaction type iv disease 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
656 salmonellosis 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
657 uveal disease 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
658 stomatitis 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
659 cholangitis, primary sclerosing 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
660 dilated cardiomyopathy 9.3 TNF IL6 IL4 IL1B IL17A CD4
661 disease by infectious agent 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
662 primary biliary cholangitis 9.3 TNF IL6 IL4 IL1B IL17A CXCL8
663 chorioretinitis 9.3 TNF IL6 IL1B IL17A CXCL10 CD4
664 sebaceous gland disease 9.3 TNF IL6 IL1B IL1A IL17A FLG
665 rhinitis 9.3 TSLP TNF IL6 IL4 IL1B IL17A
666 bronchitis 9.2 TNF TAC1 IL6 IL4 IL1B IL13
667 autoimmune disease 9.2 TNF IL6 IL4 IL1B IL1A IL17A
668 immune system disease 9.2 TNF IL6 IL4 IL1B IL17A IL13
669 pneumonia 9.2 TNF IL6 IL4 IL1B IL17A IL13
670 nephrotic syndrome 9.2 TNF IL6 IL4 IL1B IL17A IL13
671 bronchiolitis 9.2 TNF IL6 IL4 IL1B IL17A IL13
672 combined immunodeficiency 9.2 TNF IL6 IL4 IL1B IL17A IL13
673 mycobacterium tuberculosis 1 9.2 TNF IL6 IL4 IL17A CXCL10 CD4
674 myocarditis 9.2 TNF IL6 IL4 IL1B IL1A IL17A
675 trichinosis 9.2 TSLP TNF IL6 IL4 IL17A IL13
676 childhood-onset asthma 9.2 TSLP IL4 IL17A IL13 CD4 CCL17
677 bronchopneumonia 9.1 TNF IL6 IL1B IL17A CXCL8 CXCL10
678 lymph node disease 9.1 TNF IL6 IL1B IL17A CXCL8 CXCL10
679 parasitic ectoparasitic infectious disease 9.1 TNF IL6 IL4 IL31 IL1B IL13
680 pulmonary disease, chronic obstructive 9.1 TNF TAC1 IL6 IL1B IL17A IL13
681 dry eye syndrome 9.1 TNF TAC1 IL6 IL1B IL1A IL17A
682 corneal disease 9.1 TNF TAC1 IL6 IL1B IL1A IL17A
683 thrombocytopenia 9.1 TNF IL6 IL4 IL1B IL1A CXCL8
684 blepharitis 9.1 TNF IL6 IL4 IL1B IL17A IL13
685 commensal bacterial infectious disease 9.1 TNF IL6 IL4 IL1B IL17A IL13
686 potocki-shaffer syndrome 9.1 TNF IL6 IL4 IL1B IL17A CXCL10
687 autoimmune disease of gastrointestinal tract 9.1 TNF IL6 IL4 IL1B IL17A IL13
688 systemic scleroderma 9.1 TNF IL6 IL4 IL1B IL17A IL13
689 food allergy 9.1 TSLP TNF IL4 IL17A IL13 FLG
690 body mass index quantitative trait locus 11 9.1 TNF IL6 IL4 IL1B IL17A IL13
691 parasitic helminthiasis infectious disease 9.1 TSLP TNF IL6 IL4 IL1B IL17A
692 intrinsic asthma 9.0 TSLP TNF IL6 IL4 IL17A IL13
693 acute asthma 9.0 TSLP TNF IL6 IL4 IL17A IL13
694 opportunistic mycosis 9.0 TNF IL6 IL4 IL1B IL1A IL17A
695 alopecia areata 9.0 TNF KRT16 IL6 IL4 IL1B IL1A
696 bone inflammation disease 9.0 TNF IL6 IL4 IL1B IL1A IL17A
697 bacterial pneumonia 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
698 coccidiosis 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
699 severe covid-19 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
700 extrapulmonary tuberculosis 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
701 extrinsic cardiomyopathy 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
702 coronavirus infectious disease 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
703 chagas disease 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
704 temporal arteritis 9.0 TNF IL6 IL4 IL1B IL17A CXCL8
705 lacrimal apparatus disease 9.0 TNF TAC1 IL6 IL4 IL1B IL1A
706 chronic conjunctivitis 8.9 TSLP TNF IL6 IL4 IL1B IL17A
707 paranasal sinus disease 8.9 TSLP TNF IL6 IL4 IL1B IL17A
708 allergic conjunctivitis 8.9 TSLP TNF IL6 IL4 IL1B IL17A
709 visceral leishmaniasis 8.9 TNF IL6 IL4 IL1B IL17A IL13
710 trypanosomiasis 8.9 TNF IL6 IL4 IL1B IL1A IL17A
711 lipoprotein quantitative trait locus 8.9 TNF IL6 IL4 IL1B IL1A IL17A
712 inflammatory bowel disease 8.9 TNF TAC1 IL6 IL4 IL1B IL1A
713 diabetes mellitus 8.9 TNF TAC1 IL6 IL4 IL1B IL1A
714 leukocyte disease 8.8 TNF IL6 IL4 IL1B IL17A IL13
715 parasitic protozoa infectious disease 8.8 TNF IL6 IL4 IL1B IL17A IL13
716 autoimmune disease of central nervous system 8.8 TNF IL6 IL4 IL1B IL17A IL13
717 leprosy 3 8.8 TNF IL6 IL4 IL1B IL17A IL13
718 viral infectious disease 8.8 TNF IL6 IL4 IL1B IL17A IL13
719 colitis 8.8 TNF IL6 IL4 IL1B IL17A IL13
720 multiple sclerosis 8.8 TNF IL6 IL4 IL1B IL17A IL13
721 sarcoidosis 1 8.7 TNF TAC1 IL6 IL1B IL1A IL17A
722 peripheral nervous system disease 8.7 TNF TAC1 IL6 IL4 IL1B IL17A
723 type 2 diabetes mellitus 8.7 TNF TAC1 IL6 IL4 IL1B IL17A
724 autoimmune disease of musculoskeletal system 8.7 TNF IL6 IL4 IL1B IL1A IL17A
725 primary bacterial infectious disease 8.7 TNF IL6 IL4 IL1B IL1A IL17A
726 behcet syndrome 8.7 TNF IL6 IL4 IL1B IL1A IL17A
727 immune deficiency disease 8.7 TNF IL6 IL4 IL1B IL1A IL17A
728 eye disease 8.7 TNF IL6 IL4 IL1B IL1A IL17A
729 connective tissue disease 8.7 TNF IL6 IL4 IL1B IL1A IL17A
730 malaria 8.7 TNF IL6 IL4 IL1B IL1A IL17A
731 chronic asthma 8.7 TSLP TNF IL6 IL4 IL1B IL17A
732 systemic lupus erythematosus 8.7 TNF IL6 IL4 IL1B IL1A IL17A
733 common cold 8.6 TSLP TNF IL6 IL4 IL1B IL17A
734 celiac disease 1 8.6 TSLP TNF IL6 IL4 IL1B IL17A
735 rheumatoid arthritis 8.6 TNF IL6 IL4 IL1B IL1A IL17A
736 respiratory allergy 8.6 TSLP TNF IL6 IL4 IL1B IL17A
737 conjunctival disease 8.5 TSLP TNF IL6 IL4 IL1B IL1A
738 nervous system disease 8.4 TNF TAC1 IL6 IL4 IL1B IL1A
739 hypertension, essential 8.4 TNF TAC1 IL6 IL4 IL1B IL1A
740 cystic fibrosis 8.4 TNF IL6 IL4 IL1B IL1A IL17A
741 respiratory failure 8.3 TNF TAC1 IL6 IL4 IL1B IL17A
742 bronchial disease 8.3 TSLP TNF IL6 IL4 IL1B IL17A
743 interstitial lung disease 2 8.2 TSLP TNF IL6 IL4 IL1B IL1A
744 autoimmune disease of skin and connective tissue 8.2 TNF LORICRIN KRT16 IVL IL6 IL4
745 nose disease 8.2 TSLP TNF TAC1 IL6 IL4 IL31
746 nasal cavity disease 8.2 TSLP TNF TAC1 IL6 IL4 IL31
747 integumentary system disease 7.8 TSLP TNF LORICRIN IVL IL6 IL4
748 asthma 7.8 TSLP TNF TAC1 IL6 IL4 IL31

Graphical network of the top 20 diseases related to Irritant Dermatitis:



Diseases related to Irritant Dermatitis

Symptoms & Phenotypes for Irritant Dermatitis

Symptoms:

11 (showing 1, show less)
  • erythema

MGI Mouse Phenotypes related to Irritant Dermatitis:

45 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.93 CCL17 CD4 CXCL10 IL13 IL17A IL1A
2 digestive/alimentary MP:0005381 9.86 CD4 IL13 IL17A IL4 IL6 KRT16
3 hematopoietic system MP:0005397 9.73 CCL17 CD4 CXCL10 IL13 IL17A IL1A
4 integument MP:0010771 9.4 CD4 IL13 IL17A IL1A IL1B IL4

Drugs & Therapeutics for Irritant Dermatitis

Drugs for Irritant Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 20, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sage Approved
2
Mineral oil Approved, Vet_approved 8042-47-5
3
Miconazole Approved, Investigational, Vet_approved 22916-47-8 4189
4
Clotrimazole Approved, Vet_approved 23593-75-1 2812
5
Zinc oxide Approved 1314-13-2
6
Zinc cation Approved, Experimental, Investigational 7440-66-6, 23713-49-7 32051
7
Petrolatum Approved, Investigational 8009-03-8
8 Kava Approved, Investigational, Nutraceutical 9000-38-8
9
Capric acid Experimental 59906-14-8, 334-48-5 2969
10 Anesthetics
11 Radiation-Protective Agents
12 Sunscreening Agents
13 Dermatologic Agents
14 Anti-Infective Agents, Local
15 Emollients
16
Nickel 7440-02-0 934
17 Anti-Infective Agents
18 Antifungal Agents
19 Protective Agents
20 Pharmaceutical Solutions

Interventional clinical trials:

(showing 24, show less)
# Name Status NCT ID Phase Drugs
1 A Randomized Controlled Clinical Study Comparing the Efficacy and Safety of Calmoseptine vs Destin Maximum Strength Diaper Rash Paste in Treatment of Incontinence Associated Dermatitis in Older Children and Adults Completed NCT02080247 Phase 3 Skin care regimen with Calmoseptine ointment;Skin care regimen with Destin ointment
2 Treatment of Incontinence Associated Dermatitis - Automated Unknown status NCT03046810
3 Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners Completed NCT03483025
4 Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis Completed NCT03685929
5 Specific Factors Associated With the Development of Incontinence- Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence: Matched Case Control Study Completed NCT02996357
6 Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery: A Randomised, Controlled Trial Completed NCT03231813
7 An Open Label Study of the Therapeutic Effects of Tetrix Cream in Allergic Contact and Irritant Contact Dermatitis Completed NCT00646867
8 A Turn and Positioning System and Standardized Incontinence Care Combined With Tailored Repositioning Versus a Standard Repositioning Protocol for Pressure Ulcer Prevention: A Multicenter Prospective Randomized Controlled Clinical Trial and Health Economical Analysis in a Hospital Setting Completed NCT02690753
9 "Developing Of A New Incontinence Care Product, And Investigation Of The Effect Of Its On Perineal Dermatitis in Woman Patients Fecal Incontinence" Completed NCT02991833 Early Phase 1
10 Enhancing SKIN Health and Safety in Aged CARE: An Exploratory Cluster Randomized Pragmatic Trial in Aged Nursing Home Residents (SKINCARE) Completed NCT03824886
11 Comparison Between the Effect of Zinc Oxide and Non-irritant Barrier Film on the Prevention of Incontinence-Associated Dermatitis in Hospitalized Elderly in a Teaching Hospital Completed NCT03309059
12 A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD) Completed NCT02724449
13 The Effects of Repeated Exposure to Antiseptics During COVID-19 Pandemic on Skin Parameters Recruiting NCT05276102
14 A Single Center Explorative Study of the Treamtent ofDiabetes Patients With Contact Dermatitits Caused byInsulin Infusion Pump or Glucose Monitor Recruiting NCT04909983
15 Investigation of Nickel Sensitization After Percutaneous Implantation of Patent Foramen Ovale Occluder; a RandomizEd Trial. Recruiting NCT04713683
16 Controlled Crossover Study to Evaluate the Efficacy of the handLITE LED Device in Treating the Signs of Contact/Irritant Dermatitis of the Hand Not yet recruiting NCT05497921
17 Comparison of Two Skin Protection Regimes for the Prevention of Incontinence-associated Dermatitis in Geriatric Care: an Exploratory Trial (PID) Not yet recruiting NCT05403762
18 Adjuvant Effect of Photobiomodulation in the Treatment of Incontinence-associated Dermatitis in Adults - a Randomized Controlled Clinical Trial Not yet recruiting NCT05471180
19 Can the Use of Uricap Female, a New Urine Collecting Device, Lead to Better Care for Women > 75+Years With Urinary Incontinence? Not yet recruiting NCT05275257
20 EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment Terminated NCT04793711
21 A Total Body Wash Wipe Combined With a Genital Wipe Versus Standard Care (Water and pH Neutral Soap) for Washing of Incontinent Residents in a Long- Term Care Setting: a Multicenter Prospective Randomised Controlled Clinical Trial and Health Economical Analysis in Nursing Homes Terminated NCT02475512
22 Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier Terminated NCT02570139
23 Effects of an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis Compared to Hospital Standard Care Practice: an Exploratory Randomized Controlled Trial Terminated NCT03298113
24 Evaluate the Efficacy of Two Advanced Skin Treatment Regimens in Treating Incontinence-associated Dermatitis: Cluster Randomization Study Terminated NCT04625426

Search NIH Clinical Center for Irritant Dermatitis

Cochrane evidence based reviews: dermatitis, irritant

Genetic Tests for Irritant Dermatitis

Anatomical Context for Irritant Dermatitis

Organs/tissues related to Irritant Dermatitis:

MalaCards : Skin, T Cells, Neutrophil, Spinal Cord, Liver, Breast, Myeloid

Publications for Irritant Dermatitis

Articles related to Irritant Dermatitis:

(showing 1833, show less)
# Title Authors PMID Year
1
Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018. 62
35940370 2022
2
Bullous irritant contact dermatitis caused by the spitting palm, Euphorbia leuconeura BOISSIER. 62
35895285 2022
3
The ability of critical care nurses to identify pressure injury and incontinence-associated dermatitis: A multicentre cross-sectional survey. 62
36266743 2022
4
Comparison between patch test results of natural dyes and standard allergens in batik workers with occupational contact dermatitis. 62
35771736 2022
5
Psychometric properties of the Chinese version of the knowledge, attitudes and practices of the incontinence-associated dermatitis questionnaire (C-KAP-IAD-Q) used with Chinese nurses. 62
36089903 2022
6
A clinical evaluation of a permanent hair dye designed to reduce allergic contact dermatitis and hair damage. 62
35790071 2022
7
[Contact dermatitis caused by elastic bands from surgical mask]. 62
34804264 2022
8
Comparison of two skin protection regimes for the Prevention of Incontinence-associated Dermatitis in geriatric care (PID): a study protocol for an exploratory randomised controlled pragmatic trial. 62
36175092 2022
9
Is Patch Test Necessary in Children to Solve the Clinical Conundrum of Foot Eczema. 62
34999604 2022
10
Thiamethoxam-Induced Subclinical Onychomadesis. 62
36161079 2022
11
Bacterial invasion into the epidermis of rats with sodium lauryl sulphate-irritated skin increases damage and induces incontinence-associated dermatitis. 62
35916389 2022
12
The prevalence of skin lesions and associated factors in hospitalised adult patients with cancer. 62
36001701 2022
13
Ulcerative vulvar irritant contact dermatitis from eutectic mixture of local anesthetics cream in 2 patients. 62
35769194 2022
14
Profile of Nonvenereal Female Genital Dermatoses: A Cross-Sectional Study From Eastern India. 62
35763612 2022
15
Prevalence and Patterns of Latex Glove Allergy among Healthcare Workers in a Tertiary Care Center In South India - A Cross-Sectional Study. 62
36262582 2022
16
[Therapeutic peculiarities in diseases of the nipple skin]. 62
35925215 2022
17
[Occupational Dermatoses in Healthcare Workers during the COVID-19 Pandemic: A Narrative Review]. 62
35766244 2022
18
A Structured Skin Care Protocol for Preventing and Treating Incontinence-associated Dermatitis in Critically Ill Patients. 62
35703853 2022
19
Deployed Airbag Causes Bullous Reaction Following a Motor Vehicle Accident. 62
35960968 2022
20
Profile of Dermatological Disorders Among Workers Involved in Fruit Growing Industry of Kashmir Valley in North India. 62
36226016 2022
21
Corrigendum to "Development and validation of the incontinence associated dermatitis knowledge, attitude and practice questionnaire" [J Tissue Viability 29 (2020) 244-251]. 62
34229900 2022
22
The costs, health outcomes and cost-effectiveness of interventions for the prevention and treatment of incontinence-associated dermatitis: A systematic review. 62
35364428 2022
23
Moisture-Associated Skin Damage: Expanding Practice Based on the Newest ICD-10-CM Codes for Irritant Contact Dermatitis Associated With Digestive Secretions and Fecal or Urinary Effluent From an Abdominal Stoma or Enterocutaneous Fistula. 62
35523238 2022
24
Evaluating the Scales Used To Diagnose Incontinence-Associated Dermatitis: A Systematic Review. 62
35442923 2022
25
Novel insights into contact dermatitis. 62
35183605 2022
26
Irritant contact dermatitis caused by cosmetics containing excessive mercury. 62
35445522 2022
27
Quality and clinical applicability of recommendations for incontinence-associated dermatitis: A systematic review of guidelines and consensus statements. 62
35411654 2022
28
Development and Psychometric Testing of a Knowledge Instrument on Incontinence-Associated Dermatitis for Clinicians: The Know-IAD: Erratum. 62
35255061 2022
29
Severe irritant contact dermatitis from olanexidine gluconate and subsequent skin sensitization. 62
34837390 2022
30
Clinician Knowledge of Incontinence-Associated Dermatitis: A Multisite Survey of Healthcare Professionals in Acute and Subacute Settings. 62
35255068 2022
31
Bullous impetigo-like irritant contact dermatitis caused by perfume. 62
35014095 2022
32
New Key Players in Irritant Contact Dermatitis: Residential Skin Cells and Neutrophils Drive Inflammation. 62
34749986 2022
33
Moisture-Associated Skin Damage: Expanding and Updating Practice Based on the Newest ICD-10-CM Codes. 62
35255065 2022
34
Aberrant HO-1/NQO1-Reactive Oxygen Species-ERK Signaling Pathway Contributes to Aggravation of TPA-Induced Irritant Contact Dermatitis in Nrf2-Deficient Mice. 62
35197329 2022
35
CCL2‒CCR2 Signaling in the Skin Drives Surfactant-Induced Irritant Contact Dermatitis through IL-1β‒Mediated Neutrophil Accumulation. 62
34560074 2022
36
Contact dermatitis and nutrition. 62
35183401 2022
37
Successful management of moisture-, friction-, and trauma-associated skin damage in the pediatric and neonatal population using cyanoacrylate skin protectant. 62
35273126 2022
38
[Translated article] Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). 62
35339268 2022
39
Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). 62
35526918 2022
40
The transcriptome of hand eczema assessed by tape stripping. 62
34812515 2022
41
Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reports. 62
35039780 2022
42
[Pressure sores-A multilayered challenge]. 62
34994853 2022
43
Facial masks vestibulitis: the risk of mismanagement in the COVID-19 pandemic. 62
35075074 2022
44
Skin injuries due to Personal Protective Equipment and preventive measures in the COVID-19 context: an integrative review. 62
35476010 2022
45
An Exploratory Study of the Effects of the pH of Synthetic Urine on Skin Integrity in Healthy Participants. 62
35093947 2022
46
Occupational contact allergy of construction workers in Greece: Trends during 2009-2018. 62
34510477 2022
47
Skin barrier response to active chlorine hand disinfectant-An experimental study comparing skin barrier response to active chlorine hand disinfectant and alcohol-based hand rub on healthy skin and eczematous skin. 62
34420240 2022
48
Improving Recovery of Irritant Hand Dermatitis in Healthcare Workers With Workplace Interventions During the COVID-19 Pandemic. 62
35923967 2022
49
Emerging Links between Microbiome Composition and Skin Immunology in Diaper Dermatitis: A Narrative Review. 62
35053737 2022
50
Irritant Contact Dermatitis - a Review. 62
35433115 2022
51
Nickel dust-induced occupational contact dermatitis by welding and grinding work in shipyard workers: a report of nine cases. 62
35425617 2022
52
Development and Psychometric Testing of a Knowledge Instrument on Incontinence-Associated Dermatitis for Clinicians: The Know-IAD. 62
35040816 2022
53
Development of CPP-Based Methods for Delivery of miRNAs into the Skin and Airways: Lessons from Cell Culture and Mouse Models. 62
34766310 2022
54
Exacerbating factors and disease burden in patients with atopic dermatitis. 62
34764038 2022
55
Real-World Evidence of an Emollient Device for Atopic and Contact Dermatitis in Pediatric to Adult Patients - Data from a Post-Marketing Surveillance. 62
36101562 2022
56
Causes of irritant contact dermatitis after occupational skin exposure: a systematic review. 62
34665298 2022
57
Facial Irritant Contact Dermatitis Caused by Pyraclostrobin. 62
35996399 2022
58
Occupational Contact Dermatitis Caused by Artichokes. 62
34967769 2022
59
Skin Treatment with Detergent Induces Dermatitis with H1-Antihistamine-Refractory Itch and Upregulates IL-4 and Th17/Th22 Cytokine Gene Expression in C57BL/6 Mice. 62
35933977 2022
60
Occupational Contact Dermatitis in Dental Personnel: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001 to 2018. 62
35029351 2022
61
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2016. 62
34149001 2022
62
Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016. 62
33039486 2021
63
Effectiveness of skin cleanser and protectant regimen on incontinence-associated dermatitis outcomes in acute care patients: A cluster randomised trial. 62
33960676 2021
64
Contact Dermatitis: Classifications and Management. 62
34264448 2021
65
Unique molecular signatures typify skin inflammation induced by chemical allergens and irritants. 62
34174113 2021
66
Irritant Contact Dermatitis Due to Euphorbia milii: No Rose Without a Thorn. 62
33795562 2021
67
Incontinence and Incontinence-Associated Dermatitis in Acute Care: A Retrospective Analysis of Total Cost of Care and Patient Outcomes From the Premier Healthcare Database. 62
34781311 2021
68
Assessing absorbent products' effectiveness for the prevention and management of incontinence-associated dermatitis caused by urinary, faecal or double adult incontinence: A systematic review. 62
34376333 2021
69
Are Topical Corticosteroids Effective for Chronic Irritant Contact Dermatitis? 62
33978601 2021
70
Possible involvement of zinc deficiency in epidermal growth factor receptor inhibitor-induced xerotic dermatitis. 62
34235777 2021
71
A Qualitative Study on the Experience and Training Needs of ICU Nurses for Incontinence-Associated Dermatitis. 62
34546204 2021
72
Establishment of incontinence-associated dermatitis rat models and assessment of the therapeutic effects of zinc oxide, painless skin protective film and silicone dressing. 62
34434272 2021
73
Healing of a Large Wound Defect Post Debridement, with PRF Therapy and High Dose Oral Vitamin C, in a Patient of Severe Irritant Contact Dermatitis Due to Slaked Lime: A Case Report. 62
35283594 2021
74
Concurrent diffuse dermal angiomatosis and granuloma inframammary adultorum of the breast. 62
35130388 2021
75
Facial Mask-related Acne and Acneiform Eruption During the Coronavirus Disease 2019 Pandemic: A Case Series. 62
34976287 2021
76
Occupational Dermatoses Related to Personal Protective Equipment Used During the COVID-19 Pandemic. 62
34556245 2021
77
The History of Surfactants and Review of Their Allergic and Irritant Properties. 62
34524773 2021
78
Promoting effect of acylated homoserine lactone on the healing of tissue damage in model rats with incontinence-associated dermatitis. 62
34597169 2021
79
What You Need to Know About Hand Hygiene and Dermatitis During the Coronavirus Pandemic. 62
34535513 2021
80
Safety Profile for Microneedling: A Systematic Review. 62
34448760 2021
81
Plant Dermatitis: More Than Just Poison Ivy. 62
34826273 2021
82
Effectiveness of Semiocclusive Sodium Carboxymethyl Cellulose Fibers and Hydrocolloid Dressings for Irritant Peristomal Dermatitis: A Case Series. 62
34415254 2021
83
Investigating the release of inflammatory cytokines in a human model of incontinence-associated dermatitis. 62
34144890 2021
84
Environmental Causes of Dermatitis. 62
34225895 2021
85
Preparation and evaluation of benzalkonium chloride hand sanitizer as a potential alternative for alcohol-based hand gels. 62
34408542 2021
86
Psychometric properties of the Chinese version of the attitude towards the prevention of incontinence-associated dermatitis (C-APrIAD) among Chinese nurses. 62
33820693 2021
87
Fifty Years With a Brooke Ileostomy: An Autobiographical Case Report. 62
34527460 2021
88
Prevention and management of moisture-associated skin damage. 62
34379461 2021
89
Aquatic Antagonists: Sea Cucumbers (Holothuroidea). 62
34735314 2021
90
Wood ash and water: Cause of superficial alkaline burns in a toddler. 62
34096087 2021
91
Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies. 62
33951706 2021
92
Mast Cell-Specific Deletion of Group III Secreted Phospholipase A2 Impairs Mast Cell Maturation and Functions. 62
34359862 2021
93
Postoperative morbidity and mortality after anterior resection with preventive diverting loop ileostomy versus loop colostomy for rectal cancer: A updated systematic review and meta-analysis. 62
33622575 2021
94
Development and Implementation of a Simple Wound Care Guideline for Minor Skin Lesions: A Quality Improvement Project. 62
34186545 2021
95
A Smart Diaper System Using Bluetooth and Smartphones to Automatically Detect Urination and Volume of Voiding: Prospective Observational Pilot Study in an Acute Care Hospital. 62
34328427 2021
96
Peristomal Punctate Pemphigus. 62
33156025 2021
97
Moisturizers and Cleansers in the Management of Skin Conditions Caused by Personal Protective Equipment and Frequent Handwashing. 62
34347397 2021
98
Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016. 62
33454963 2021
99
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis. 62
34322217 2021
100
Anti-inflammatory effect of amygdalin analogs following topical administration on the TPA-induced irritant contact dermatitis model in mice. 62
33449397 2021
101
Painful scrotal dermatitis secondary to topical 5-fluorouracil. 62
34387061 2021
102
Irritant contact dermatitis caused by zinc oxide eugenol and formocresol used in dental operation. 62
33169905 2021
103
Irritant contact dermatitis following extracorporeal shockwave therapy: a case report. 62
33548985 2021
104
Moisture-associated skin damage (MASD): A best practice recommendation from Wund-D.A.CH. 62
33942514 2021
105
Effects of constant light exposure on allergic and irritant contact dermatitis in mice reared under constant light conditions. 62
33629775 2021
106
Allergic contact versus irritant contact dermatitis in patients with hard-to-heal leg ulcer: clinical and diagnostic approach. 62
33979220 2021
107
Structured diagnostic assessment of hand eczema in cleaning workers. 62
33768711 2021
108
Does the presence of bacterial urinary infection contribute to the development of incontinence-associated dermatitis? A scoping review. 62
33579585 2021
109
A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis. 62
33141477 2021
110
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): A real-life retrospective cohort multicenter study on 438 subjects with chronic hand eczema. 62
33619833 2021
111
Skin tape stripping identifies gene transcript signature associated with allergic contact dermatitis. 62
33236775 2021
112
Conceptual Framework for Incontinence-Associated Dermatitis Based on Scoping Review and Expert Consensus Process. 62
33951713 2021
113
Contact leukoderma following irritant contact dermatitis to an isopropanol-based hand rub: A consequence of rigorous hand hygiene. 62
33188701 2021
114
Masks use and facial dermatitis during COVID-19 outbreak: is there a difference between CE and non-CE approved masks? Multi-center, real-life data from a large Italian cohort. 62
33960753 2021
115
Scalp involvement in patients referred for patch testing: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 1996 to 2016. 62
32822786 2021
116
Eyelid dermatitis in patients referred for patch testing: Retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. 62
32679276 2021
117
Allergic contact dermatitis and other occupational skin diseases in health care workers in the Finnish Register of Occupational Diseases in 2005-2016. 62
33277706 2021
118
Hairdressers' occupational skin diseases in the Finnish Register of Occupational Diseases in a period of 14 years. 62
33104233 2021
119
Comparison of patients' diagnoses in a dermatology outpatient clinic during the COVID-19 pandemic period and pre-pandemic period. 62
33332694 2021
120
Occupational respiratory and skin diseases among workers exposed to metalworking fluids. 62
33394701 2021
121
Rare Operative Intervention for Urinary and Fecal Incontinence-Associated Dermatitis. 62
33914693 2021
122
Management of incontinence-associated dermatitis with topical antibiotics and antifungal medication. 62
33856927 2021
123
Incontinence-associated dermatitis: who is affected? 62
33856906 2021
124
Efficacy of a comprehensive strategy to reduce moisture-associated skin damage in an intensive care unit: A quasi-experimental study. 62
33308944 2021
125
Double blind randomized repetitive efficacy test of various occupational skin protection preparations against sodium lauryl sulphate. 62
33768641 2021
126
Developments in silicone technology for use in stoma care. 62
34106775 2021
127
COVID-19 and dermatological personal protective equipment considerations. 62
34219927 2021
128
Irritant Contact Dermatitis With Topical Povidone-Iodine Ointment Post Ear Surgery. 62
31547715 2021
129
Corneocyte Nanotexture as Biomarker for Individual Susceptibility to Skin Irritants. 62
32914835 2021
130
Facial Personal Protective Equipment: Materials, Resterilization Methods, and Management of Occupation-Related Dermatoses. 62
33273243 2021
131
A case of COVID-19 with papulovesicular rash that progressed to retiform purpura, accompanied by cherry angiomas. 62
33566880 2021
132
The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation. 62
33683077 2021
133
Contact Dermatitis of the Hands: Is It Irritant or Allergic? 62
33956604 2021
134
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis. 62
33729576 2021
135
Oleic acid exhibits an expressive anti-inflammatory effect in croton oil-induced irritant contact dermatitis without the occurrence of toxicological effects in mice. 62
33091495 2021
136
Optical coherence tomography for patch test grading: A prospective study on its use for noninvasive diagnosis of allergic contact dermatitis. 62
33012002 2021
137
Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis. 62
33606414 2021
138
Management of incontinence-associated dermatitis: A systematic review of monetary data. 62
33236846 2021
139
Which Characteristics of Fecal Incontinence Predispose Incontinence-Associated Dermatitis? A Classification and Regression Tree Analysis. 62
33284153 2021
140
Implementing best available evidence into practice for incontinence-associated dermatitis in Australia: A multisite multimethod study protocol. 62
33158742 2021
141
Synthetic hair extensions causing irritant contact dermatitis in patients with a history of atopy: A report of 10 cases. 62
33641162 2021
142
Clinical manifestations and progression, seasonal variation, and environmental factors associated with Paederus dermatitis among patients attending the outpatient dermatology clinic of Thailand's largest national tertiary referral center: a prospective cohort study. 62
33525888 2021
143
Occupational dermatitis to facial personal protective equipment in health care workers: A systematic review. 62
33011325 2021
144
Pediatric allergic contact dermatitis. Part I: Clinical features and common contact allergens in children. 62
33217510 2021
145
Development of a Need-based Interventional Skin Care Protocol on Incontinence-associated Dermatitis among Critically Ill Patients. 62
33707893 2021
146
Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review. 62
34729012 2021
147
Contact allergen sensitivity in children with contact dermatitis. 62
34013230 2021
148
Unilateral Koilonychia Secondary to Chemical Depilatory Product. 62
33614715 2021
149
Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study. 62
33377285 2021
150
The Use of a Stoma Rod/Bridge to Prevent Retraction: A Systematic Review. 62
33427808 2021
151
Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment. 62
34194861 2021
152
Clinical relevance of positive patch test reactions to lanolin: A ROAT study. 62
32844454 2021
153
Ubiquity, Hazardous Effects, and Risk Assessment of Fragrances in Consumer Products. 62
33520600 2021
154
Clinical Manifestations, Treatment, and Prevention of Acute Irritant Contact Dermatitis Caused by 2,4-Dichloro-5-Methylpyrimidine. 62
31688132 2021
155
A Case of Contact Allergic Dermatitis to Topical Minoxidil. 62
33564516 2021
156
Fluctuating Palmar Erythema in a Toddler during COVID-19 Pandemic: Do You Know the Offender? 62
33620073 2021
157
Irritant contact dermatitis in healthcare workers as a result of the COVID-19 pandemic: a cross-sectional study. 62
32705718 2021
158
Topical and Systemic Retinoids for the Treatment of Genital Warts: A Systematic Review and Meta-Analysis. 62
33279886 2021
159
Occupational skin disease in mining: an Australian case series. 62
33372583 2021
160
Adverse Reactions to Sunscreens. 62
34698020 2021
161
The effectiveness of faecal collection devices in preventing incontinence-associated dermatitis in critically ill patients with faecal incontinence: A systematic review and meta-analysis. 62
32646766 2021
162
Topical and systemic retinoids for the treatment of cutaneous viral warts: A systematic review and meta-analysis. 62
33278051 2021
163
Paederus Dermatitis Outbreak in Addis Ababa, Ethiopia: A Case-Control Study. 62
33815513 2021
164
Topical Applications of a Novel Emollient Inhibit Inflammation in Murine Models of Acute Contact Dermatitis. 62
33954180 2021
165
Machine-learning-driven biomarker discovery for the discrimination between allergic and irritant contact dermatitis. 62
33318199 2020
166
Contact dermatitis: etiologies of the allergic and irritant type. 62
33348937 2020
167
Art of prevention: Practical interventions in lip-licking dermatitis. 62
33898702 2020
168
Art of prevention: Allergic sensitization through damaged skin: Atopic, occupational, and stasis dermatitis. 62
33898703 2020
169
COVID-19: An overview for dermatologists. 62
33107038 2020
170
Combination of urease inhibitor and antiseptic inhibits urea decomposition-induced ammonia production by Proteus mirabilis. 62
32851777 2020
171
NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation. 62
32896817 2020
172
[Hand eczema and wet work]. 62
33463511 2020
173
Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey. 62
33135831 2020
174
Irritant contact dermatitis, multiple pyogenic granulomas and vitiligo following topical application of tretinoin. 62
32621665 2020
175
Contact dermatitis due to masks and respirators during COVID-19 pandemic: What we should know and what we should do. 62
33174266 2020
176
Development and validation of the incontinence associated dermatitis knowledge, attitude and practice questionnaire. 62
32773358 2020
177
The Prevalence of Incontinence-Associated Dermatitis in Hospitalized Patients in China: A Systematic Review and Meta-Analysis. 62
32941231 2020
178
Differential role of lipoteichoic acids isolated from Staphylococcus aureus and Lactobacillus plantarum on the aggravation and alleviation of atopic dermatitis. 62
32736014 2020
179
Cutaneous manifestations in an Italian military COVID hub. 62
33295741 2020
180
Moisture associated skin damage (MASD) in intensive care patients: A Norwegian point-prevalence study. 62
32536519 2020
181
Ostomy Complications, Risk Factors, and Applied Nursing Care: A Retrospective, Descriptive Study. 62
32903201 2020
182
Clinico-Demographic Profile of Patients with Foot Dermatitis: A Cross-Sectional Study with Special Reference to Patch Test Results. 62
33165432 2020
183
Contact Dermatitis from Hand Hygiene Practices in the COVID-19 Pandemic. 62
33241256 2020
184
COVID-19 reopening causes high risk of irritant contact dermatitis in children. 62
32800064 2020
185
Irritant contact dermatitis after a curious therapeutic use of oregano essential oil. 62
32232859 2020
186
Lessons Learned About Peristomal Skin Complications: Secondary Analysis of the ADVOCATE Trial. 62
32618958 2020
187
The effect of the "stay-at-home" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak. 62
32401401 2020
188
Fox-Fordyce Disease: Dermoscopic Perspective. 62
32903893 2020
189
Challenging a paradigm: skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis. 62
31562780 2020
190
Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black population. 62
32915939 2020
191
Are Topical Corticoids Efficacious in Acute Irritant Dermatitis: The Evidence. 62
32665512 2020
192
Knowledge Gaps in the Etiology and Pathophysiology of Incontinence-Associated Dermatitis: A Scoping Review. 62
33290017 2020
193
Adverse cutaneous reaction to diabetic glucose sensors and insulin pumps: Irritant contact dermatitis or allergic contact dermatitis? 62
32212168 2020
194
Contact dermatitis: Clinical practice findings from a single tertiary referral hospital, a 4-Year retrospective study. 62
32817780 2020
195
Efficacy of Incontinence-Associated Dermatitis Intervention for Patients in Intensive Care: An Open-Label Pilot Randomized Controlled Trial. 62
32544117 2020
196
Frequent handwashing amidst the COVID-19 outbreak: prevention of hand irritant contact dermatitis and other considerations. 62
32346616 2020
197
Isobornyl acrylate and diabetic devices steal the Show for the 2020 American Contact Dermatitis Society Allergen of the Year. 62
32716991 2020
198
12-year data on dermatologic cases in the Finnish Register of Occupational Diseases I: Distribution of different diagnoses and main causes of allergic contact dermatitis. 62
32037572 2020
199
Moisture-associated skin damage: causes and an overview of assessment, classification and management. 62
32579457 2020
200
Skin diseases affecting a population occupationally exposed to terrestrial fauna and flora in Brittany over a 15-year period. 62
32588595 2020
201
CD44 expression in human skin: High expression in irritant and allergic contact dermatitis and moderate expression in psoriasis lesions in comparison with healthy controls. 62
31900953 2020
202
Contact Dermatitis Associated With Nail Care Products: Retrospective Analysis of North American Contact Dermatitis Group Data, 2001-2016. 62
32355091 2020
203
Irritant contact dermatitis due to Euphorbia trigona. 62
31782156 2020
204
Anogenital Dermatitis in Men Who Have Sex with Men. 62
32115132 2020
205
Prospective trial for the clinical efficacy of anogenital skin care with miconazole nitrate-containing soap for diaper candidiasis. 62
32030818 2020
206
A case of irritant contact dermatitis and suspected linagliptin-induced koebnerized bullous pemphigoid. 62
32258308 2020
207
The role of Candida spp. contamination and efficacy of camphorated oil in skin care of incontinent associated dermatitis patients. 62
32352935 2020
208
Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators. 62
32181649 2020
209
Maintaining skin integrity in the aged: A systematic review. 62
31945604 2020
210
Moisture-associated skin damage: an overview of its diagnosis and management. 62
32160066 2020
211
Developments in silicone technology for use in stoma care. 62
32207652 2020
212
Hand eczema treatment: Change behaviour with text messaging, a randomized trial. 62
31794053 2020
213
Comparison of safety of loop ileostomy and loop transverse colostomy for low-lying rectal cancer patients undergoing anterior resection: A retrospective, single institution, propensity score-matched study. 62
32199033 2020
214
Safety and efficacy of a defecation care algorithm based on ultrasonographic bowel observation in Japanese home-care settings: a single-case, multiple-baseline study. 62
31910312 2020
215
Association between incontinence, incontinence-associated dermatitis and pressure injuries: A multisite study among hospitalised patients 65 years or older. 62
31509889 2020
216
Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice. 62
31724251 2020
217
[Using Teamwork to Reduce the Incidence of Incontinence-Associated Dermatitis]. 62
31960400 2020
218
Oral administration of whole dihomo-γ-linolenic acid-producing yeast suppresses allergic contact dermatitis in mice. 62
31532348 2020
219
[Incontinence-associated dermatitis: a position paper]. 62
31538217 2020
220
The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study. 62
32273745 2020
221
Severe irritant reaction following sequential waxing and use of a chemical depilatory cream in an adolescent. 62
31769049 2020
222
Study of the cytotoxic and irritant effects of skin cleansing soaps. 62
33372931 2020
223
A forgotten parasitic infestation in an immunocompromised patient-a case report of crusted scabies. 62
33708329 2020
224
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma. 62
32850308 2020
225
Incontinence-associated dermatitis in elderly patients: prevalence and risk factors. 62
32696899 2020
226
Dyshidrosiform Bullous Pemphigoid: Case Reports and Review. 62
32064205 2020
227
Facial Dermatitis in Male Patients Referred for Patch Testing: Retrospective Analysis of North American Contact Dermatitis Group Data, 1994 to 2016. 62
31774459 2020
228
Topical hydrogel containing Achyrocline satureioides oily extract (free and nanocapsule) has anti-inflammatory effects and thereby minimizes irritant contact dermatitis. 62
33206785 2020
229
Management of incontinence-associated dermatitis patients using a skin protectant in acute care: a case series. 62
31930942 2020
230
Incontinence associated dermatitis in elderly people admitted to a university hospital. 62
32965435 2020
231
Does Adherence to World Health Organization Hand Hygiene Protocols in the Operating Room Have the Potential to Produce Irritant Contact Dermatitis in Anesthesia Providers? 62
31743176 2019
232
Possible roles of basophils in chronic itch. 62
29894005 2019
233
Oleylamine-induced pustular irritant contact dermatitis. 62
31389016 2019
234
Damage control: Differentiating incontinence-associated dermatitis from pressure injury. 62
31764470 2019
235
Skin Disease in Korean Human Immunodeficiency Virus Patient. 62
33911663 2019
236
Prevalence and Management of Urinary Incontinence in a Brazilian Hospital: A Prospective, Descriptive Study. 62
31887106 2019
237
Tandem repeated irritation test (TRIT) studies and clinical relevance: Post 2006. 62
29886752 2019
238
Irritant contact dermatitis caused by a shower cream used as a leave-on product. 62
31265145 2019
239
Triclosen and Its Alternatives in Antibacterial Soaps. 62
31688130 2019
240
Modifiable patient-related factors associated with pressure ulcers on the sacrum and heels: Secondary data analyses. 62
31287188 2019
241
Outcome measurement instruments for erythema associated with incontinence-associated dermatitis: Systematic review. 62
31197869 2019
242
Combination treatment with lipoteichoic acids isolated from Lactobacillus plantarum and Staphylococcus aureus alleviates atopic dermatitis via upregulation of CD55 and CD59. 62
31454521 2019
243
In Vivo Reflectance Confocal Microscopy: Emerging Role in Noninvasive Diagnosis and Monitoring of Eczematous Dermatoses. 62
31202471 2019
244
Histopathology of sabra dermatitis: A case report. 62
31033007 2019
245
Fiberglass dermatitis: clinical presentations, prevention, and treatment - a review of literatures. 62
30816574 2019
246
Botulinum neurotoxin A is an effective treatment for irritant dermatitis caused by ostomy leaks in patients with retractile stomas. 62
30843191 2019
247
A Survey of Turkish Nurses' Knowledge of Incontinence-Associated Dermatitis. 62
31513132 2019
248
Assessment and documentation of incontinence-associated dermatitis after implementation of a standardised instrument: a comparative study. 62
31509491 2019
249
Microfluidics-based skin irritation test using in vitro 3D angiogenesis platform. 62
31431937 2019
250
Exploring Incontinence-Associated Dermatitis in a Single Center Intensive Care Unit: A Longitudinal Point Prevalence Survey. 62
31513128 2019
251
Occupationally Related Nickel Reactions: A Retrospective Analysis of the North American Contact Dermatitis Group Data 1998-2016. 62
31524759 2019
252
Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. 62
31238095 2019
253
Phospholipase Cγ1 is required for normal irritant contact dermatitis responses and sebaceous gland homeostasis. 62
31338881 2019
254
Differences in itch and pain behaviors accompanying the irritant and allergic contact dermatitis produced by a contact allergen in mice. 62
31875186 2019
255
A Novel Approach to Treating Moderate to Severe Incontinence-Associated Dermatitis and Intertriginous Dermatitis: A Case Series. 62
31397740 2019
256
IL6Rα function in myeloid cells modulates the inflammatory response during irritant contact dermatitis. 62
31165501 2019
257
A Case of Irritant Contact Dermatitis Associated with Pulsatilla koreana. 62
33911697 2019
258
Four Cases of Perineal Groove-Experience of a Greek Maternity Hospital. 62
31443289 2019
259
Bullous irritant contact dermatitis caused by an alcoholic extract from Juglans regia leaves. 62
30740710 2019
260
Laxative-Induced Contact Dermatitis. 62
29746360 2019
261
Context for Practice: Epidemiology and Pathophysiology of Incontinence-Associated Dermatitis, Stoma Bridges, Root Cause Analysis for Pressure Injury, and Onychomycosis. 62
31274852 2019
262
Examining Prevalence and Risk Factors of Incontinence-Associated Dermatitis Using the International Pressure Ulcer Prevalence Survey. 62
31276451 2019
263
Decreasing Incontinence-Associated Dermatitis in the Surgical Intensive Care Unit: A Quality Improvement Project. 62
31107858 2019
264
Keratinocyte-specific deletion of the IL-6RΑ exacerbates the inflammatory response during irritant contact dermatitis. 62
31158415 2019
265
How to manage incontinence-associated dermatitis in older adults. 62
31265344 2019
266
Delphi procedure in core outcome set development: rating scale and consensus criteria determined outcome selection. 62
30922885 2019
267
Time of Onset to Changes in Skin Condition During Exposure to Synthetic Urine: A Prospective Study. 62
31274862 2019
268
Economic Model for Cost Containment: Evaluating the Utilization of a Touch-free Zinc Oxide in an Acute Care Hospital. 62
31453030 2019
269
Phytodermatitis in East and southeast of Turkey: A prospective study. 62
30585511 2019
270
Filaggrin gene mutations in hand eczema patients in the Indian subcontinent: A prospective case-control study. 62
30681730 2019
271
Contact dermatitis and sensitization in professional musicians. 62
30499108 2019
272
Contact Dermatitis in the Elderly: Predisposing Factors, Diagnosis, and Management. 62
31037642 2019
273
"Slime" contact dermatitis: Case report and review of relevant allergens. 62
30865309 2019
274
Epidemiology of Incontinence-Associated Dermatitis and Intertriginous Dermatitis (Intertrigo) in an Acute Care Facility. 62
30870318 2019
275
Evaluation of Disposable Protective Garments against Isocyanate Permeation and Penetration from Polyurethane Anticorrosion Coatings. 62
31066890 2019
276
Cariniana domestica fruit peels present topical anti-inflammatory efficacy in a mouse model of skin inflammation. 62
30617548 2019
277
Caring for patients with urinary incontinence-associated dermatitis. 62
31070964 2019
278
PROTECT - Trial: A cluster RCT to study the effectiveness of a repositioning aid and tailored repositioning to increase repositioning compliance. 62
30549321 2019
279
Enhancing SKIN health and safety in aged CARE (SKINCARE Trial): a study protocol for an exploratory cluster-randomized pragmatic trial. 62
31142364 2019
280
Impact of water exposure on skin barrier permeability and ultrastructure. 62
30417381 2019
281
Epidermal loss of phospholipase Cδ1 attenuates irritant contact dermatitis. 62
30791982 2019
282
Determining Risk Factors to Develop a Predictive Model of Incontinence-associated Dermatitis Among Critically Ill Patients with Fecal Incontinence: A Prospective, Quantitative Study. 62
30994472 2019
283
Thermography: High sensitivity and specificity diagnosing contact dermatitis in patch testing. 62
30598404 2019
284
Design and psychometric testing of the attitude towards the prevention of incontinence-associated dermatitis instrument (APrIAD). 62
30588746 2019
285
A painful periumbilical rash. 62
31191154 2019
286
A review of non-glove personal protective equipment-related occupational dermatoses reported to EPIDERM between 1993 and 2013. 62
30430597 2019
287
Biotin Is Required for the Zinc Homeostasis in the Skin. 62
31022908 2019
288
Non-glaucoma periocular allergic, atopic, and irritant dermatitis at an academic institution: A retrospective review. 62
29985741 2019
289
Associations Between Immune Phenotype and Inflammation in Murine Models of Irritant Contact Dermatitis. 62
30517752 2019
290
Euphorbia myrsinites Sap-Induced Phytodermatitis: A Prototype of Irritant Contact Dermatitis? 62
30829799 2019
291
Tabernaemontana catharinensis leaves exhibit topical anti-inflammatory activity without causing toxicity. 62
30445106 2019
292
Perineal Assessment Tool (PAT-C): Validation of a Chinese Language Version and Identification of a Clinically Validated Cut Point Using ROC Curve Analysis. 62
30844871 2019
293
Periwound Challenges Improve Patient Satisfaction in Wound Care. 62
31044112 2019
294
Moisture-associated skin damage: use of a skin protectant containing manuka honey. 62
30925233 2019
295
Immediate irritant dermatitis from the passionvine hopper (Scolypopa australis). 62
29869388 2019
296
Photocontact Dermatitis and Its Clinical Mimics: an Overview for the Allergist. 62
29951786 2019
297
The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment. 62
29754191 2019
298
Irritant Contact Dermatitis. 62
30293200 2019
299
Mechanics hands in patients with antisynthetase syndrome: 25 cases. 62
30595338 2019
300
How to improve the assessment of the impact of occupational diseases at a national level? The Netherlands as an example. 62
30297528 2019
301
Occupational dermatoses among healthcare workers in a hospital center in Portugal. 62
32368662 2019
302
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese Patients. 62
30745959 2019
303
Comparison of safety of loop ileostomy and loop transverse colostomy for low-lying rectal cancer patients undergoing anterior resection: A retrospective, single institute, propensity score-matched study. 62
30941960 2019
304
Tabernaemontana catharinensis leaves effectively reduce the irritant contact dermatitis by glucocorticoid receptor-dependent pathway in mice. 62
30404072 2019
305
Preventing and treating incontinence-associated dermatitis in adults. 62
30589590 2019
306
Prevention and Management of Incontinence-Associated Dermatitis in the Pediatric Population: An Integrative Review. 62
30608338 2019
307
Development of a New Incontinence Containment Product and an Investigation of Its Effect on Perineal Dermatitis in Patients With Fecal Incontinence: A Pilot Study in Women. 62
30724746 2019
308
A slime of the times: Two cases of acute irritant contact dermatitis from homemade slime. 62
30152559 2019
309
IL-6 Negatively Regulates IL-22Rα Expression on Epidermal Keratinocytes: Implications for Irritant Contact Dermatitis. 62
31781680 2019
310
Skin Biophysical Parameters and Patch Test Results in People Predisposing to Xiaotong Tiegao Induced Irritant Contact Dermatitis. 62
30915152 2019
311
Prevalence of Moisture-Associated Skin Damage in an Acute Care Setting: Outcomes From a Quality Improvement Project. 62
30608341 2019
312
Diagnostic utility of skin autofluorescence when patch test results are doubtful. 62
30055047 2019
313
Nasturtium officinale R. Br. effectively reduces the skin inflammation induced by croton oil via glucocorticoid receptor-dependent and NF-κB pathways without causing toxicological effects in mice. 62
30339978 2019
314
Prevention and management of moisture-associated skin damage. 62
31468844 2019
315
An experimental study of friction between volar forearm skin and nonwoven fabrics used in disposable absorbent products for incontinence. 62
30340442 2019
316
Interdisciplinary and multiprofessional outpatient secondary individual prevention of work-related skin diseases in the metalworking industry: 1-year follow-up of a patient cohort. 62
30541516 2018
317
Erratum: Incontinence-associated dermatitis: a cohort study in critically ill patients. 62
30517229 2018
318
Cultivating Incontinence-associated Dermatitis Prevention Practices in an Australian Local Health District: A Quasi-experimental Study. 62
30516479 2018
319
Transcriptional profiling of irritant contact dermatitis (ICD) in a mouse model identifies specific patterns of gene expression and immune-regulation. 62
30171875 2018
320
Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice. 62
30145688 2018
321
IRRITANT AND ALLERGIC CONTACT DERMATITIS - SKIN LESION CHARACTERISTICS. 62
31168208 2018
322
Incontinence-Associated Dermatitis: State of the Science and Knowledge Translation. 62
30303813 2018
323
Incontinence-Associated Dermatitis (IAD): Prevalence and Associated Factors in 4 Hospitals in Southeast Norway. 62
30395129 2018
324
Incidence and risk factors of incontinence-associated dermatitis among patients in the intensive care unit. 62
29964368 2018
325
Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. 62
28884598 2018
326
Minimum Data Set for Incontinence-Associated Dermatitis (MDS-IAD) in adults: Design and pilot study in nursing home residents. 62
30389338 2018
327
Gerontodermatology: the fragility of the epidermis in older adults. 62
30365203 2018
328
Dry skin in home care: A representative prevalence study. 62
30487067 2018
329
Report of the proceedings of a UK skin safety advisory group. 62
30418847 2018
330
Skin injury prevalence and incidence in China: a multicentre investigation. 62
30307811 2018
331
Incontinence-associated dermatitis: what nurses need to know. 62
30346810 2018
332
The prevention and treatment of incontinence-associated dermatitis. 62
30346820 2018
333
Perianal infectious dermatitis: An underdiagnosed, unremitting and stubborn condition. 62
30627524 2018
334
pH in nature, humans and skin. 62
29863755 2018
335
Durability of an Advanced Skin Protectant Compared With Other Commercially Available Products in Healthy Human Volunteers. 62
30256746 2018
336
Evaluation of Validity and Reliability of a Revised Incontinence-Associated Skin Damage Severity Instrument (IASD.D.2) by 3 Groups of Nursing Staff. 62
30188393 2018
337
A new treatment regimen with permethrin in scabies. 62
27982546 2018
338
Specific barrier response profiles after experimentally induced skin irritation in vivo. 62
29607504 2018
339
Impact of climate change on dermatological conditions related to flooding: update from the International Society of Dermatology Climate Change Committee. 62
29377078 2018
340
Erosio interdigitalis blastomycetica: A review of interdigital candidiasis. 62
30677843 2018
341
The Ghent Global IAD Monitoring Tool (GLOBIAD-M) to monitor the healing of incontinence-associated dermatitis (IAD): Design and reliability study. 62
29797507 2018
342
Influence of digestive enzymes on development of incontinence-associated dermatitis: Inner tissue damage and skin barrier impairment caused by lipidolytic enzymes and proteases in rat macerated skin. 62
29877066 2018
343
The role of skin barrier in occupational contact dermatitis. 62
29894020 2018
344
Core outcome domains in incontinence-associated dermatitis research. 62
29520848 2018
345
Incontinence, Incontinence-Associated Dermatitis, and Pressure Injuries in a Health District in Australia: A Mixed-Methods Study. 62
29994863 2018
346
Incontinence-associated dermatitis in the critically ill patient: an intensive care perspective. 62
29266568 2018
347
Textile and Shoe Allergic Contact Dermatitis in Military Personnel. 62
30024451 2018
348
The Impact of Microclimate on Skin Health With Absorbent Incontinence Product Use: An Integrative Review. 62
29994862 2018
349
Insertion site assessment of peripherally inserted central catheters: Inter-observer agreement between nurses and inpatients. 62
29560795 2018
350
Using Alternative Light Source Technology to Enhance Visual Inspection of the Skin. 62
29994864 2018
351
Patch Testing to Propylene Glycol: The Mayo Clinic Experience. 62
29923851 2018
352
Moisture-associated skin damage: cause, risk and management. 62
29944429 2018
353
Incontinence-associated dermatitis: a consensus on its severity assessment. 62
29897114 2018
354
[Type IV contact allergies in the food processing industry: an update]. 62
29721627 2018
355
Distribution of childhood skin diseases according to age and gender, a single institution experience. 62
30116131 2018
356
A recalcitrant case of Jacquet erosive diaper dermatitis after surgery for Hirschsprung disease in a boy with Waardenburg-Shah syndrome. 62
30142718 2018
357
[Hand eczema in children. Clinical and epidemiological study of the population referred to a tertiary hospital]. 62
28838840 2018
358
A Non-Peptidic S100A9 Specific Ligand for Optical Imaging of Phagocyte Activity In Vivo. 62
29185197 2018
359
Damage control: Differentiating incontinence-associated dermatitis from pressure injury. 62
29757867 2018
360
Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. 62
29315488 2018
361
Incontinence-Associated Dermatitis and Intertriginous Dermatitis as Nurse-Sensitive Quality Indicators: A Delphi Study. 62
29722751 2018
362
Occupational Contact Dermatitis in the Canadian Aircraft Industry. 62
29762207 2018
363
Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units. 62
29428583 2018
364
Incontinence-associated dermatitis from a urinary incontinence perspective. 62
29749768 2018
365
Genital Allergic Contact Dermatitis. 62
29698355 2018
366
Incontinence-associated dermatitis in older people: prevention and management. 62
29708792 2018
367
The Blend of Taurine and Aloe Vera Extract Boosts Action Against Skin Irritation: In Vitro and Clinical Evaluations. 62
30052195 2018
368
Exfoliative Cheilitis as a Manifestation of Factitial Cheilitis. 62
29974020 2018
369
Case Report: Paederus Dermatitis in the Returning Traveler. 62
29611499 2018
370
Recurrent Granuloma Gluteale Infantum Secondary to Fecal Overflow Incontinence. 62
30283312 2018
371
Skin diseases of the vulva: eczematous diseases and contact urticaria. 62
28780897 2018
372
The association of smoking with contact dermatitis and hand eczema - a review. 62
28960277 2018
373
Cutting Edge: Nqo1 Regulates Irritant Contact Hypersensitivity against Croton Oil through Maintenance of Dendritic Epidermal T Cells. 62
29378915 2018
374
Diagnosis and management of diaper dermatitis in infants with emphasis on skin microbiota in the diaper area. 62
28986935 2018
375
A Case of a Paediatric Patient With Allergic Contact Dermatitis to Benzoyl Peroxide. 62
28922933 2018
376
Potential of EPR spin-trapping to investigate in situ free radicals generation from skin allergens in reconstructed human epidermis: cumene hydroperoxide as proof of concept. 62
29334799 2018
377
Efficacy and Cost-Effectiveness Analysis of Evidence-Based Nursing Interventions to Maintain Tissue Integrity to Prevent Pressure Ulcers and Incontinence-Associated Dermatitis. 62
29210516 2018
378
Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options. 62
29243033 2018
379
Eugenol as a Promising Molecule for the Treatment of Dermatitis: Antioxidant and Anti-inflammatory Activities and Its Nanoformulation. 62
30647816 2018
380
Recent advances in understanding and managing contact dermatitis. 62
29983912 2018
381
Preventing skin damage and incontinence-associated dermatitis in older people. 62
29368563 2018
382
Incontinence-Associated Dermatitis, Characteristics and Relationship to Pressure Injury: A Multisite Epidemiologic Analysis. 62
29300291 2018
383
The Acid Mantle: A Myth or an Essential Part of Skin Health? 62
30125885 2018
384
Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis. 62
28296664 2018
385
Stigmasterol Alleviates Cutaneous Allergic Responses in Rodents. 62
30140696 2018
386
Dermatoses among automobile mechanics in Mansoura, Egypt. 62
28157439 2018
387
Unilateral Palmar Callus and Irritant Hand Eczema - Underreported Signs of Dependency on Crutches. 62
29483998 2018
388
Imaging, myeloid precursor immortalization, and genome editing for defining mechanisms of leukocyte recruitment in vivo. 62
29721088 2018
389
Propylene Glycol. 62
29059092 2018
390
Neural Stem Cells and Its Derivatives as a New Material for Melanin Inhibition. 62
29271951 2017
391
[Treatment of incontinence associated dermatitis]. 62
29179848 2017
392
Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis. 62
28774591 2017
393
Successful strategy to decrease indwelling catheter utilization rates in an academic medical intensive care unit. 62
28844376 2017
394
A Prospective, Multicenter Study to Compare a Disposable, High-fluid Capacity Underpad to Nonpermeable, Disposable, Reusable Containment Products on Incontinence-associated Dermatitis Rates Among Skilled Nursing Facility Residents. 62
29324430 2017
395
Development of an Animal Model for Inducing Various Degrees of Severity of Incontinence-Associated Dermatitis. 62
28891827 2017
396
Neonatal skin care: what should we do? A four-week follow-up randomized controlled trial at Zagazig University Hospitals. 62
28884798 2017
397
Prevention and management of incontinence-associated dermatitis. 62
29125346 2017
398
Effect of a 1-Piece Drainable Pouch on Incontinence-Associated Dermatitis in Intensive Care Unit Patients With Fecal Incontinence: A Comparison Cohort Study. 62
29117083 2017
399
Do Intra-anal Bowel Management Devices Reduce Incontinence-Associated Dermatitis and/or Pressure Injuries? 62
29117085 2017
400
Associations between skin barrier characteristics, skin conditions and health of aged nursing home residents: a multi-center prevalence and correlational study. 62
29132305 2017
401
Core Outcome Sets (COS) for clinical trials in health- and nursing science: the case of Incontinence-Associated Dermatitis (IAD). 62
27623993 2017
402
No Sting Barrier Film to Protect Skin in Adult Patients: Findings From a Scoping Review With Implications for Evidence-Based Practice. 62
28759158 2017
403
Irritant contact keratitis caused by the bodily fluids of a brown marmorated stink bug. 62
29296555 2017
404
CONSIDER - Core Outcome Set in IAD Research: study protocol for establishing a core set of outcomes and measurements in incontinence-associated dermatitis research. 62
27682261 2017
405
Independent risk factors for the development of skin erosion due to incontinence (incontinence-associated dermatitis category 2) in nursing home residents: results from a multivariate binary regression analysis. 62
27933731 2017
406
Incontinence Briefs Containing Spiral-Shaped Fiber Acidify Skin pH of Older Nursing Home Residents at Risk for Incontinence-Associated Dermatitis. 62
28877114 2017
407
Context for Practice: Prevention of Pressure Injury and Incontinence-Associated Dermatitis. 62
28877105 2017
408
Effects of a Skin Barrier Cream on Management of Incontinence-Associated Dermatitis in Older Women: A Cluster Randomized Controlled Trial. 62
28723852 2017
409
Dermatitis of the Foot: Epidemiologic and Clinical Features in 389 Children. 62
28730653 2017
410
Classification and possible bacterial infection in outpatients with eczema and dermatitis in China: A cross-sectional and multicenter study. 62
28858126 2017
411
Atopic and Contact Dermatitis of the Vulva. 62
28778637 2017
412
Paederus Dermatitis: A Case Series. 62
28979873 2017
413
Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis. 62
27817210 2017
414
Comparing the effectiveness and wash-off resistance of skin barrier creams: a healthy volunteer study. 62
28880764 2017
415
Skin Health Connected to the Use of Absorbent Hygiene Products: A Review. 62